ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-397014,Muscle contraction,3/11,205/10899,9.678906362405491e-4,0.10670421163306468,0.06502749739411144,ITPR2/VIM/KCNE4,3
R-HSA-9614085,FOXO-mediated transcription,2/11,65/10899,0.0018606026326156476,0.10670421163306468,0.06502749739411144,SREBF1/CDKN1A,2
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,2/11,108/10899,0.005047581434179437,0.10670421163306468,0.06502749739411144,VIM/CDKN1A,2
R-HSA-5576891,Cardiac conduction,2/11,132/10899,0.007453860200189482,0.10670421163306468,0.06502749739411144,ITPR2/KCNE4,2
R-HSA-9702518,STAT5 activation downstream of FLT3 ITD mutants,1/11,10/10899,0.01005108609123051,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-2206281,Mucopolysaccharidoses,1/11,11/10899,0.011051126320177351,0.10670421163306468,0.06502749739411144,NAGLU,1
R-HSA-264870,Caspase-mediated cleavage of cytoskeletal proteins,1/11,12/10899,0.012050248069853997,0.10670421163306468,0.06502749739411144,VIM,1
R-HSA-5607763,CLEC7A (Dectin-1) induces NFAT activation,1/11,13/10899,0.013048452099543528,0.10670421163306468,0.06502749739411144,ITPR2,1
R-HSA-198323,AKT phosphorylates targets in the cytosol,1/11,14/10899,0.01404573916797125,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,1/11,14/10899,0.01404573916797125,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-5576893,Phase 2 - plateau phase,1/11,15/10899,0.015042110033304468,0.10670421163306468,0.06502749739411144,KCNE4,1
R-HSA-139853,Elevation of cytosolic Ca2+ levels,1/11,16/10899,0.01603756545315327,0.10670421163306468,0.06502749739411144,ITPR2,1
R-HSA-9703648,Signaling by FLT3 ITD and TKD mutants,1/11,16/10899,0.01603756545315327,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,1/11,17/10899,0.01703210618457074,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,1/11,17/10899,0.01703210618457074,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",1/11,17/10899,0.01703210618457074,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-1368082,RORA activates gene expression,1/11,18/10899,0.01802573298405319,0.10670421163306468,0.06502749739411144,SREBF1,1
R-HSA-9703465,Signaling by FLT3 fusion proteins,1/11,19/10899,0.019018446607541373,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-5625900,RHO GTPases activate CIT,1/11,20/10899,0.020010247810420045,0.10670421163306468,0.06502749739411144,RHOB,1
R-HSA-5627117,RHO GTPases Activate ROCKs,1/11,20/10899,0.020010247810420045,0.10670421163306468,0.06502749739411144,RHOB,1
R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,1/11,21/10899,0.02100113734751763,0.10670421163306468,0.06502749739411144,RHOB,1
R-HSA-5218921,VEGFR2 mediated cell proliferation,1/11,21/10899,0.02100113734751763,0.10670421163306468,0.06502749739411144,ITPR2,1
R-HSA-2024096,HS-GAG degradation,1/11,22/10899,0.021991115973108433,0.10670421163306468,0.06502749739411144,NAGLU,1
R-HSA-9613829,Chaperone Mediated Autophagy,1/11,22/10899,0.021991115973108433,0.10670421163306468,0.06502749739411144,VIM,1
R-HSA-9013422,RHOBTB1 GTPase cycle,1/11,23/10899,0.022980184440911766,0.10670421163306468,0.06502749739411144,VIM,1
R-HSA-2029485,Role of phospholipids in phagocytosis,1/11,25/10899,0.024955593915260477,0.10670421163306468,0.06502749739411144,ITPR2,1
R-HSA-400685,Sema4D in semaphorin signaling,1/11,25/10899,0.024955593915260477,0.10670421163306468,0.06502749739411144,RHOB,1
R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,1/11,25/10899,0.024955593915260477,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-114508,Effects of PIP2 hydrolysis,1/11,27/10899,0.02692737178923521,0.10670421163306468,0.06502749739411144,ITPR2,1
R-HSA-191273,Cholesterol biosynthesis,1/11,27/10899,0.02692737178923521,0.10670421163306468,0.06502749739411144,SREBF1,1
R-HSA-76002,"Platelet activation, signaling and aggregation",2/11,263/10899,0.027635789033763576,0.10670421163306468,0.06502749739411144,ITPR2/RHOB,2
R-HSA-9682385,FLT3 signaling in disease,1/11,28/10899,0.027911900754496566,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",1/11,29/10899,0.028895524072654832,0.10670421163306468,0.06502749739411144,SREBF1,1
R-HSA-418360,Platelet calcium homeostasis,1/11,30/10899,0.02987824249355664,0.10670421163306468,0.06502749739411144,ITPR2,1
R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,1/11,32/10899,0.03184096764021349,0.10670421163306468,0.06502749739411144,ITPR2,1
R-HSA-2871809,FCERI mediated Ca+2 mobilization,1/11,33/10899,0.032820975862902,0.10670421163306468,0.06502749739411144,ITPR2,1
R-HSA-5663084,Diseases of carbohydrate metabolism,1/11,34/10899,0.03380008218220143,0.10670421163306468,0.06502749739411144,NAGLU,1
R-HSA-114604,GPVI-mediated activation cascade,1/11,35/10899,0.034778287345201386,0.10670421163306468,0.06502749739411144,RHOB,1
R-HSA-1296065,Inwardly rectifying K+ channels,1/11,35/10899,0.034778287345201386,0.10670421163306468,0.06502749739411144,KCNJ8,1
R-HSA-9615710,Late endosomal microautophagy,1/11,35/10899,0.034778287345201386,0.10670421163306468,0.06502749739411144,VIM,1
R-HSA-9706574,RHOBTB GTPase Cycle,1/11,35/10899,0.034778287345201386,0.10670421163306468,0.06502749739411144,VIM,1
R-HSA-390522,Striated Muscle Contraction,1/11,36/10899,0.035755592098442035,0.10670421163306468,0.06502749739411144,VIM,1
R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,1/11,36/10899,0.035755592098442035,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-9006925,Intracellular signaling by second messengers,2/11,309/10899,0.03721607423683879,0.10670421163306468,0.06502749739411144,ITPR2/CDKN1A,2
R-HSA-111465,Apoptotic cleavage of cellular proteins,1/11,38/10899,0.03770750335905293,0.10670421163306468,0.06502749739411144,VIM,1
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,1/11,38/10899,0.03770750335905293,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-9675126,Diseases of mitotic cell cycle,1/11,38/10899,0.03770750335905293,0.10670421163306468,0.06502749739411144,CDKN1A,1
R-HSA-9664323,FCGR3A-mediated IL10 synthesis,1/11,40/10899,0.03965582192536332,0.10888499371945097,0.06635650586780947,ITPR2,1
R-HSA-2426168,Activation of gene expression by SREBF (SREBP),1/11,42/10899,0.041600553749920666,0.10888499371945097,0.06635650586780947,SREBF1,1
R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,1/11,42/10899,0.041600553749920666,0.10888499371945097,0.06635650586780947,ITPR2,1
R-HSA-1489509,DAG and IP3 signaling,1/11,43/10899,0.04257157649181542,0.10888499371945097,0.06635650586780947,ITPR2,1
R-HSA-9646399,Aggrephagy,1/11,43/10899,0.04257157649181542,0.10888499371945097,0.06635650586780947,VIM,1
R-HSA-69231,Cyclin D associated events in G1,1/11,47/10899,0.04644673030065316,0.112316638727034,0.06844781307464677,CDKN1A,1
R-HSA-69236,G1 Phase,1/11,47/10899,0.04644673030065316,0.112316638727034,0.06844781307464677,CDKN1A,1
R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,1/11,47/10899,0.04644673030065316,0.112316638727034,0.06844781307464677,SREBF1,1
R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,1/11,48/10899,0.04741328816710144,0.11260655939686592,0.06862449603133104,CDKN1A,1
R-HSA-112043,PLC beta mediated events,1/11,51/10899,0.05030762019352286,0.11738444711822002,0.07153622816068811,ITPR2,1
R-HSA-75153,Apoptotic execution phase,1/11,52/10899,0.05127061947245659,0.11756883430752978,0.07164859708492119,VIM,1
R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,1/11,55/10899,0.05415429344101774,0.11822787433007477,0.07205022812359128,NAGLU,1
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),1/11,55/10899,0.05415429344101774,0.11822787433007477,0.07205022812359128,SREBF1,1
R-HSA-112040,G-protein mediated events,1/11,56/10899,0.055113745928305535,0.11822787433007477,0.07205022812359128,ITPR2,1
R-HSA-5578775,Ion homeostasis,1/11,56/10899,0.055113745928305535,0.11822787433007477,0.07205022812359128,ITPR2,1
R-HSA-186797,Signaling by PDGF,1/11,58/10899,0.05702999706075651,0.12039666046159708,0.07337192604307856,THBS4,1
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,1/11,60/10899,0.05894271463117162,0.12249032884290353,0.07464784583224039,CDKN1A,1
R-HSA-4086398,Ca2+ pathway,1/11,62/10899,0.06085190450492328,0.12451235844853532,0.07588010764176668,ITPR2,1
R-HSA-373755,Semaphorin interactions,1/11,65/10899,0.06370908769351169,0.12646681425335132,0.07707118874165456,RHOB,1
R-HSA-69563,p53-Dependent G1 DNA Damage Response,1/11,66/10899,0.06465972458066083,0.12646681425335132,0.07707118874165456,CDKN1A,1
R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,1/11,66/10899,0.06465972458066083,0.12646681425335132,0.07707118874165456,CDKN1A,1
R-HSA-69615,G1/S DNA Damage Checkpoints,1/11,68/10899,0.06655836647015823,0.12822980333885922,0.07814558652229647,CDKN1A,1
R-HSA-400253,Circadian Clock,1/11,70/10899,0.06845350403803763,0.12822980333885922,0.07814558652229647,SREBF1,1
R-HSA-9013026,RHOB GTPase cycle,1/11,70/10899,0.06845350403803763,0.12822980333885922,0.07814558652229647,RHOB,1
R-HSA-9012999,RHO GTPase cycle,2/11,449/10899,0.07282996404436548,0.13219114761849468,0.08055970214977518,VIM/RHOB,2
R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,1/11,77/10899,0.07505897297339914,0.13219114761849468,0.08055970214977518,CDKN1A,1
R-HSA-422356,Regulation of insulin secretion,1/11,78/10899,0.0759991274085583,0.13219114761849468,0.08055970214977518,ITPR2,1
R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,1/11,79/10899,0.07693841301973137,0.13219114761849468,0.08055970214977518,ITPR2,1
R-HSA-9664433,Leishmania parasite growth and survival,1/11,79/10899,0.07693841301973137,0.13219114761849468,0.08055970214977518,ITPR2,1
R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,1/11,80/10899,0.0778768305296006,0.13219114761849468,0.08055970214977518,CDKN1A,1
R-HSA-416482,G alpha (12/13) signalling events,1/11,80/10899,0.0778768305296006,0.13219114761849468,0.08055970214977518,RHOB,1
R-HSA-9663891,Selective autophagy,1/11,81/10899,0.07881438066031288,0.13219114761849468,0.08055970214977518,VIM,1
R-HSA-449147,Signaling by Interleukins,2/11,473/10899,0.07977397896872912,0.13219114761849468,0.08055970214977518,VIM/CDKN1A,2
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/11,83/10899,0.08068688167018578,0.13219114761849468,0.08055970214977518,CDKN1A,1
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,1/11,84/10899,0.08162183399097211,0.13219114761849468,0.08055970214977518,SREBF1,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/11,85/10899,0.08255592181585458,0.13219114761849468,0.08055970214977518,CDKN1A,1
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,1/11,86/10899,0.08348914586431244,0.13219114761849468,0.08055970214977518,ITPR2,1
R-HSA-418346,Platelet homeostasis,1/11,88/10899,0.08535300550721792,0.13355234979364686,0.08138924364155765,ITPR2,1
R-HSA-9616222,Transcriptional regulation of granulopoiesis,1/11,90/10899,0.0872134186648934,0.13487656607477702,0.08219624525332672,CDKN1A,1
R-HSA-111885,Opioid Signalling,1/11,92/10899,0.08907039107404313,0.13616508060744525,0.08298148956686416,ITPR2,1
R-HSA-5625740,RHO GTPases activate PKNs,1/11,95/10899,0.0918494108124347,0.13863985237418833,0.08448966072665218,RHOB,1
R-HSA-8878159,Transcriptional regulation by RUNX3,1/11,96/10899,0.09277403655114858,0.13863985237418833,0.08448966072665218,CDKN1A,1
R-HSA-4420097,VEGFA-VEGFR2 Pathway,1/11,99/10899,0.09554278123605975,0.14119099893773274,0.08604437608393686,ITPR2,1
R-HSA-5607764,CLEC7A (Dectin-1) signaling,1/11,101/10899,0.09738434104119786,0.14233095998328918,0.08673908918649205,ITPR2,1
R-HSA-1296071,Potassium Channels,1/11,103/10899,0.09922249149823192,0.14321138246893653,0.0872756347456123,KCNJ8,1
R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/11,104/10899,0.10014028999707592,0.14321138246893653,0.0872756347456123,CDKN1A,1
R-HSA-163685,Integration of energy metabolism,1/11,108/10899,0.10380298900842944,0.14381039102209495,0.08764068150930995,ITPR2,1
R-HSA-194138,Signaling by VEGF,1/11,108/10899,0.10380298900842944,0.14381039102209495,0.08764068150930995,ITPR2,1
R-HSA-8957275,Post-translational protein phosphorylation,1/11,108/10899,0.10380298900842944,0.14381039102209495,0.08764068150930995,SCG2,1
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),1/11,112/10899,0.10745213001582621,0.14582789073576416,0.08887018271985628,CDKN1A,1
R-HSA-983705,Signaling by the B Cell Receptor (BCR),1/11,112/10899,0.10745213001582621,0.14582789073576416,0.08887018271985628,ITPR2,1
R-HSA-1989781,PPARA activates gene expression,1/11,117/10899,0.11199455915567291,0.15045733704752018,0.09169145194031701,SREBF1,1
R-HSA-400206,Regulation of lipid metabolism by PPARalpha,1/11,119/10899,0.11380563866402527,0.1513614994231536,0.09224246502242049,SREBF1,1
R-HSA-8878166,Transcriptional regulation by RUNX2,1/11,121/10899,0.11561335965761133,0.1522433349946763,0.09277987174190801,CDKN1A,1
R-HSA-1630316,Glycosaminoglycan metabolism,1/11,124/10899,0.1183186561944154,0.15394265585276948,0.09381546894074595,NAGLU,1
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),1/11,125/10899,0.11921874851755832,0.15394265585276948,0.09381546894074595,SCG2,1
R-HSA-69206,G1/S Transition,1/11,131/10899,0.12460178283525591,0.15934651074124073,0.09710867690601929,CDKN1A,1
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,1/11,134/10899,0.1272820687177426,0.16122395370914064,0.09825282497509959,ITPR2,1
R-HSA-1632852,Macroautophagy,1/11,136/10899,0.12906477897933666,0.16193976985143185,0.09868905641915515,VIM,1
R-HSA-1474228,Degradation of the extracellular matrix,1/11,140/10899,0.13262027166267942,0.163319408621633,0.09952983350902843,HTRA1,1
R-HSA-5663220,RHO GTPases Activate Formins,1/11,140/10899,0.13262027166267942,0.163319408621633,0.09952983350902843,RHOB,1
R-HSA-5621481,C-type lectin receptors (CLRs),1/11,142/10899,0.1343930651481372,0.1639841987587362,0.09993496877263704,ITPR2,1
R-HSA-3858494,Beta-catenin independent WNT signaling,1/11,146/10899,0.13792877400424775,0.16676842675059045,0.10163172821365624,ITPR2,1
R-HSA-453279,Mitotic G1 phase and G1/S transition,1/11,149/10899,0.1405719339765069,0.16843303800788667,0.10264617274718857,CDKN1A,1
R-HSA-9612973,Autophagy,1/11,151/10899,0.14232994537062116,0.16901681012761263,0.10300193414979164,VIM,1
R-HSA-8957322,Metabolism of steroids,1/11,154/10899,0.14496083328738807,0.17061761794002314,0.10397749569752102,SREBF1,1
R-HSA-69242,S Phase,1/11,163/10899,0.15280953914057893,0.17773144144738615,0.10831278980173117,CDKN1A,1
R-HSA-9658195,Leishmania infection,1/11,164/10899,0.15367756215375494,0.17773144144738615,0.10831278980173117,ITPR2,1
R-HSA-109581,Apoptosis,1/11,180/10899,0.1674564217343114,0.19199744905744326,0.11700675565827566,VIM,1
R-HSA-69275,G2/M Transition,1/11,196/10899,0.18103104064564457,0.20420936637142495,0.12444892133438641,CDKN1A,1
R-HSA-2559583,Cellular Senescence,1/11,197/10899,0.18187273536235016,0.20420936637142495,0.12444892133438641,CDKN1A,1
R-HSA-453274,Mitotic G2-G2/M phases,1/11,198/10899,0.18271364359548548,0.20420936637142495,0.12444892133438641,CDKN1A,1
R-HSA-5357801,Programmed Cell Death,1/11,210/10899,0.19274343695401686,0.2136239759573687,0.13018635653911667,VIM,1
R-HSA-416476,G alpha (q) signalling events,1/11,216/10899,0.19771625478204602,0.21732447839679436,0.13244151038031793,ITPR2,1
R-HSA-5668914,Diseases of metabolism,1/11,249/10899,0.2245724378902637,0.24482077245413994,0.14919825468119333,NAGLU,1
R-HSA-1257604,PIP3 activates AKT signaling,1/11,267/10899,0.238874283633825,0.2582949570999897,0.15740966914680812,CDKN1A,1
R-HSA-69620,Cell Cycle Checkpoints,1/11,293/10899,0.25910939439526604,0.27696788827393454,0.16878929479297955,CDKN1A,1
R-HSA-71387,Metabolism of carbohydrates,1/11,295/10899,0.2606454973993034,0.27696788827393454,0.16878929479297955,NAGLU,1
R-HSA-9006931,Signaling by Nuclear Receptors,1/11,299/10899,0.26370902077725056,0.27696788827393454,0.16878929479297955,SREBF1,1
R-HSA-1474244,Extracellular matrix organization,1/11,300/10899,0.264473096321727,0.27696788827393454,0.16878929479297955,HTRA1,1
R-HSA-418594,G alpha (i) signalling events,1/11,318/10899,0.27810377467874514,0.2889672033771336,0.17610189679492907,ITPR2,1
R-HSA-195258,RHO GTPase Effectors,1/11,327/10899,0.28483263421173977,0.29366465387722007,0.17896460901104827,RHOB,1
R-HSA-195721,Signaling by WNT,1/11,332/10899,0.288546203014142,0.29520496154523757,0.17990330066468777,ITPR2,1
R-HSA-3700989,Transcriptional Regulation by TP53,1/11,362/10899,0.31046191183552085,0.3152017883520937,0.1920897325137413,CDKN1A,1
R-HSA-112316,Neuronal System,1/11,410/10899,0.34425341331701254,0.3468613937209293,0.21138367484377965,KCNJ8,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,1/11,433/10899,0.35990545549979114,0.35990545549979114,0.21933296457050985,CDKN1A,1
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,6/10,200/4383,1.5106510287852478e-6,2.4170416460563965e-5,1.9081907732024183e-5,SCG2/VIM/EMP3/GADD45B/RHOB/HTRA1,6
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,4/10,200/4383,7.113098424610385e-4,0.005690478739688308,0.004492483215543401,KLF9/GADD45B/CDKN1A/RHOB,4
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,3/10,161/4383,0.004825646050939099,0.025736778938341857,0.020318509688164628,GADD45B/CDKN1A/RHOB,3
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,2/10,105/4383,0.02256624829320222,0.09026499317280888,0.07126183671537543,ITPR2/CDKN1A,2
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,2/10,199/4383,0.07260176453054473,0.14087762809613855,0.11121918007589886,GADD45B/RHOB,2
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,2/10,200/4383,0.07324569221075306,0.14087762809613855,0.11121918007589886,EMP3/CDKN1A,2
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,2/10,200/4383,0.07324569221075306,0.14087762809613855,0.11121918007589886,GADD45B/CDKN1A,2
HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,1/10,36/4383,0.07924366580407793,0.14087762809613855,0.11121918007589886,KCNJ8,1
HALLMARK_HEDGEHOG_SIGNALING,HALLMARK_HEDGEHOG_SIGNALING,1/10,36/4383,0.07924366580407793,0.14087762809613855,0.11121918007589886,SCG2,1
HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/10,138/4383,0.2740326763583715,0.3734576480867645,0.2948349853316562,HTRA1,1
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,1/10,158/4383,0.30755475975170976,0.3734576480867645,0.2948349853316562,RHOB,1
HALLMARK_E2F_TARGETS,HALLMARK_E2F_TARGETS,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2948349853316562,CDKN1A,1
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2948349853316562,CDKN1A,1
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2948349853316562,CDKN1A,1
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2948349853316562,CDKN1A,1
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2948349853316562,CDKN1A,1
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,3/18,28/21728,1.5436970154854052e-6,0.0013846962228904085,7.149754598037667e-4,EMP3/GADD45B/HTRA1,3
MA_MYELOID_DIFFERENTIATION_UP,MA_MYELOID_DIFFERENTIATION_UP,3/18,38/21728,3.954622929824836e-6,0.0017736483840264392,9.15807415327857e-4,KLF9/EMP3/CDKN1A,3
FOROUTAN_TGFB_EMT_UP,FOROUTAN_TGFB_EMT_UP,4/18,192/21728,1.641126135852166e-5,0.004527896844461283,0.0023379388740984155,SCG2/VIM/GADD45B/HTRA1,4
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,5/18,433/21728,2.1239230316426064e-5,0.004527896844461283,0.0023379388740984155,SCG2/NAGLU/VIM/RHOB/HTRA1,5
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,3/18,70/21728,2.523911284538062e-5,0.004527896844461283,0.0023379388740984155,KLF9/ITPR2/GADD45B,3
FRIDMAN_SENESCENCE_UP,FRIDMAN_SENESCENCE_UP,3/18,77/21728,3.360537434243149e-5,0.004878131876167311,0.0025187795875299154,VIM/CDKN1A/RHOB,3
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,4/18,238/21728,3.806791876607713e-5,0.004878131876167311,0.0025187795875299154,MXRA7/KLF9/SREBF1/RHOB,4
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,4/18,266/21728,5.870089768861718e-5,0.006581838153336201,0.003398473024077837,ITPR2/SREBF1/KCNJ8/RHOB,4
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,3/18,102/21728,7.786458279067894e-5,0.007760503418137668,0.004007066248877046,KLF9/GADD45B/CDKN1A,3
FOROUTAN_INTEGRATED_TGFB_EMT_UP,FOROUTAN_INTEGRATED_TGFB_EMT_UP,3/18,118/21728,1.2004506867913076e-4,0.01076804266051803,0.005559982128296583,SCG2/GADD45B/HTRA1,3
GESERICK_TERT_TARGETS_DN,GESERICK_TERT_TARGETS_DN,2/18,21/21728,1.3485590361802852e-4,0.010996885958670143,0.00567814331023278,KLF9/GADD45B,2
WP_ADIPOGENESIS,WP_ADIPOGENESIS,3/18,131/21728,1.6356779740906628e-4,0.012226692856327704,0.006313143057893787,GADD45B/SREBF1/CDKN1A,3
WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,2/18,31/21728,2.971476004537644e-4,0.016952037844162618,0.008753032507694129,KLF9/SREBF1,2
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,3/18,162/21728,3.0575888220621313e-4,0.016952037844162618,0.008753032507694129,EMP3/CDKN1A/RHOB,3
JIANG_AGING_CEREBRAL_CORTEX_UP,JIANG_AGING_CEREBRAL_CORTEX_UP,2/18,32/21728,3.1680194824061045e-4,0.016952037844162618,0.008753032507694129,VIM/GADD45B,2
FRIDMAN_IMMORTALIZATION_DN,FRIDMAN_IMMORTALIZATION_DN,2/18,33/21728,3.370753453297162e-4,0.016952037844162618,0.008753032507694129,CDKN1A/HTRA1,2
KASLER_HDAC7_TARGETS_2_DN,KASLER_HDAC7_TARGETS_2_DN,2/18,33/21728,3.370753453297162e-4,0.016952037844162618,0.008753032507694129,GADD45B/CDKN1A,2
IBRAHIM_NRF2_DOWN,IBRAHIM_NRF2_DOWN,3/18,168/21728,3.401746724581127e-4,0.016952037844162618,0.008753032507694129,NAGLU/KLF9/VIM,3
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,3/18,175/21728,3.8337733777969333e-4,0.017589282664065207,0.009082068147848022,ITPR2/THBS4/KCNJ8,3
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,3/18,179/21728,4.0958050435870535e-4,0.017589282664065207,0.009082068147848022,KLF9/KCNJ8/RHOB,3
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,3/18,182/21728,4.2997222005493113e-4,0.017589282664065207,0.009082068147848022,EMP3/GADD45B/CDKN1A,3
LEE_AGING_MUSCLE_UP,LEE_AGING_MUSCLE_UP,2/18,38/21728,4.4769574817417546e-4,0.017589282664065207,0.009082068147848022,RHOB/HTRA1,2
FOROUTAN_PRODRANK_TGFB_EMT_UP,FOROUTAN_PRODRANK_TGFB_EMT_UP,3/18,185/21728,4.5100724779654377e-4,0.017589282664065207,0.009082068147848022,VIM/GADD45B/HTRA1,3
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,4/18,466/21728,5.033164725188133e-4,0.01878636188469814,0.009700169253379314,MXRA7/VIM/EMP3/HTRA1,4
REACTOME_MUSCLE_CONTRACTION,REACTOME_MUSCLE_CONTRACTION,3/18,195/21728,5.258796355032974e-4,0.01878636188469814,0.009700169253379314,ITPR2/VIM/KCNE4,3
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,4/18,480/21728,5.626876633466027e-4,0.01878636188469814,0.009700169253379314,MXRA7/VIM/CDKN1A/HTRA1,4
VARELA_ZMPSTE24_TARGETS_UP,VARELA_ZMPSTE24_TARGETS_UP,2/18,44/21728,6.006762613258701e-4,0.01878636188469814,0.009700169253379314,GADD45B/CDKN1A,2
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,3/18,205/21728,6.083066639387234e-4,0.01878636188469814,0.009700169253379314,ITPR2/GADD45B/HTRA1,3
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,3/18,207/21728,6.257255570003868e-4,0.01878636188469814,0.009700169253379314,NAGLU/KLF9/SREBF1,3
SAGIV_CD24_TARGETS_DN,SAGIV_CD24_TARGETS_DN,2/18,45/21728,6.283064175484328e-4,0.01878636188469814,0.009700169253379314,EMP3/CDKN1A,2
KHETCHOUMIAN_TRIM24_TARGETS_UP,KHETCHOUMIAN_TRIM24_TARGETS_UP,2/18,46/21728,6.565436800554473e-4,0.0189974090648302,0.009809141569589026,VIM/CDKN1A,2
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,3/18,222/21728,7.666286904020526e-4,0.021489560477832535,0.011095941571608656,KLF9/GADD45B/CDKN1A,3
PID_CASPASE_PATHWAY,PID_CASPASE_PATHWAY,2/18,51/21728,8.06804700126226e-4,0.02193041866706742,0.0113235747386137,VIM/SREBF1,2
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,2/18,53/21728,8.711270053357549e-4,0.022529360118185047,0.011632832778268406,VIM/RHOB,2
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,2/18,54/21728,9.04188365947226e-4,0.022529360118185047,0.011632832778268406,EMP3/CDKN1A,2
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,2/18,54/21728,9.04188365947226e-4,0.022529360118185047,0.011632832778268406,VIM/CDKN1A,2
LAU_APOPTOSIS_CDKN2A_UP,LAU_APOPTOSIS_CDKN2A_UP,2/18,55/21728,9.378486590369856e-4,0.022736493166383136,0.011739784067603806,CDKN1A/RHOB,2
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,3/18,244/21728,0.0010075765996809113,0.02378411078720467,0.012280712018271496,GADD45B/CDKN1A/RHOB,3
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,2/18,60/21728,0.0011151025235112595,0.025006174089739996,0.012911713430130376,THBS4/EMP3,2
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,2/18,60/21728,0.0011151025235112595,0.025006174089739996,0.012911713430130376,SREBF1/CDKN1A,2
DASU_IL6_SIGNALING_UP,DASU_IL6_SIGNALING_UP,2/18,61/21728,0.001152337471787635,0.025210895419353868,0.013017419450232593,SREBF1/HTRA1,2
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,2/18,63/21728,0.0012285843556164395,0.025628841092742934,0.013233221945440231,CDKN1A/RHOB,2
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,2/18,63/21728,0.0012285843556164395,0.025628841092742934,0.013233221945440231,GADD45B/CDKN1A,2
REACTOME_FOXO_MEDIATED_TRANSCRIPTION,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,2/18,66/21728,0.0013473837106153367,0.02693702805705844,0.013908692536649316,SREBF1/CDKN1A,2
KEGG_P53_SIGNALING_PATHWAY,KEGG_P53_SIGNALING_PATHWAY,2/18,68/21728,0.001429525536157908,0.02693702805705844,0.013908692536649316,GADD45B/CDKN1A,2
WP_AMPACTIVATED_PROTEIN_KINASE_AMPK_SIGNALING,WP_AMPACTIVATED_PROTEIN_KINASE_AMPK_SIGNALING,2/18,68/21728,0.001429525536157908,0.02693702805705844,0.013908692536649316,SREBF1/CDKN1A,2
WP_MELANOMA,WP_MELANOMA,2/18,68/21728,0.001429525536157908,0.02693702805705844,0.013908692536649316,GADD45B/CDKN1A,2
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,2/18,69/21728,0.0014714764490477853,0.02693702805705844,0.013908692536649316,VIM/HTRA1,2
WP_DNA_DAMAGE_RESPONSE,WP_DNA_DAMAGE_RESPONSE,2/18,69/21728,0.0014714764490477853,0.02693702805705844,0.013908692536649316,GADD45B/CDKN1A,2
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,3/18,286/21728,0.001590540433725266,0.028155924333255547,0.014538058682899067,NAGLU/CDKN1A/RHOB,3
WP_NONSMALL_CELL_LUNG_CANCER,WP_NONSMALL_CELL_LUNG_CANCER,2/18,72/21728,0.001600838507241954,0.028155924333255547,0.014538058682899067,GADD45B/CDKN1A,2
WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,2/18,74/21728,0.0016899954301686781,0.028602375487949135,0.01476857972739262,GADD45B/CDKN1A,2
WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,2/18,74/21728,0.0016899954301686781,0.028602375487949135,0.01476857972739262,VIM/CDKN1A,2
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,2/18,75/21728,0.001735445897117711,0.0288276846243442,0.014884916076643138,NAGLU/RHOB,2
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,2/18,79/21728,0.0019230405020590764,0.031217994616100544,0.01611913117536143,GADD45B/RHOB,2
ROSS_AML_WITH_PML_RARA_FUSION,ROSS_AML_WITH_PML_RARA_FUSION,2/18,80/21728,0.0019713829255510545,0.031217994616100544,0.01611913117536143,MXRA7/ITPR2,2
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,3/18,309/21728,0.001983752166240503,0.031217994616100544,0.01611913117536143,THBS4/SREBF1/CDKN1A,3
HARRIS_HYPOXIA,HARRIS_HYPOXIA,2/18,81/21728,0.0020203010963753074,0.031245001438769838,0.016133075905719337,VIM/CDKN1A,2
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,3/18,316/21728,0.0021144232930148587,0.03214640159041234,0.016598505779242424,VIM/CDKN1A/RHOB,3
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,2/18,84/21728,0.002170501305791947,0.03244899452158961,0.01675474692190275,VIM/CDKN1A,2
LEI_MYB_TARGETS,LEI_MYB_TARGETS,3/18,323/21728,0.0022503645905900386,0.03289237399183302,0.01698368192971488,KLF9/VIM/CDKN1A,3
DELASERNA_MYOD_TARGETS_UP,DELASERNA_MYOD_TARGETS_UP,2/18,86/21728,0.002273497421955014,0.03289237399183302,0.01698368192971488,CDKN1A/RHOB,2
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,2/18,87/21728,0.0023258516465696085,0.03311569725353871,0.01709899289040314,GADD45B/CDKN1A,2
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,2/18,89/21728,0.0024322680606779323,0.03408975703793914,0.017601939912800825,GADD45B/CDKN1A,2
WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,2/18,91/21728,0.002540955947757838,0.035065192079058165,0.01810559703665504,CDKN1A/RHOB,2
WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,2/18,93/21728,0.0026519083444069775,0.036041845226258466,0.01860988311864546,GADD45B/CDKN1A,2
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,2/18,94/21728,0.0027082315617632034,0.03625796583435214,0.018721475053822618,NAGLU/EMP3,2
LIM_MAMMARY_LUMINAL_MATURE_DN,LIM_MAMMARY_LUMINAL_MATURE_DN,2/18,95/21728,0.002765118301872532,0.036475163482053846,0.018833623108729325,VIM/HTRA1,2
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,3/18,353/21728,0.0028944307453846606,0.03762759969000059,0.019428673195564468,MXRA7/EMP3/HTRA1,3
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,2/18,98/21728,0.0029391510001876005,0.03766312067383254,0.01944701413657961,GADD45B/CDKN1A,2
KANG_IMMORTALIZED_BY_TERT_DN,KANG_IMMORTALIZED_BY_TERT_DN,2/18,101/21728,0.003118224270848765,0.03939503057677947,0.02034127026202308,KLF9/THBS4,2
MACAEVA_PBMC_RESPONSE_TO_IR,MACAEVA_PBMC_RESPONSE_TO_IR,2/18,106/21728,0.0034278178316860465,0.041606442820272475,0.021483113114967894,ITPR2/CDKN1A,2
WANG_HCP_PROSTATE_CANCER,WANG_HCP_PROSTATE_CANCER,2/18,106/21728,0.0034278178316860465,0.041606442820272475,0.021483113114967894,GADD45B/HTRA1,2
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,3/18,375/21728,0.0034324155726869155,0.041606442820272475,0.021483113114967894,GADD45B/SREBF1/CDKN1A,3
DOANE_BREAST_CANCER_ESR1_UP,DOANE_BREAST_CANCER_ESR1_UP,2/18,111/21728,0.0037512411148949197,0.04427451684290451,0.022860749176644945,RHOB/KCNE4,2
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2/18,111/21728,0.0037512411148949197,0.04427451684290451,0.022860749176644945,VIM/CDKN1A,2
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,3/18,389/21728,0.003804785358116367,0.04432327878221275,0.02288592696611349,EMP3/GADD45B/SREBF1,3
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,2/18,114/21728,0.00395188894043352,0.044871447842643894,0.023168969137784795,ITPR2/THBS4,2
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,2/18,114/21728,0.00395188894043352,0.044871447842643894,0.023168969137784795,CDKN1A/RHOB,2
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,2/18,115/21728,0.004019865419443817,0.045072741015513805,0.02327290505993789,GADD45B/RHOB,2
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,2/18,118/21728,0.004227064593011128,0.04681082641890101,0.024170349849576302,CDKN1A/RHOB,2
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,2/18,119/21728,0.004297218074984432,0.047007373332451655,0.02427183508335238,VIM/RHOB,2
WP_CELL_CYCLE,WP_CELL_CYCLE,2/18,122/21728,0.004510927968450103,0.048366714241917005,0.02497371855476558,GADD45B/CDKN1A,2
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,2/18,123/21728,0.004583244939312091,0.048366714241917005,0.02497371855476558,SCG2/DIRAS3,2
MARKEY_RB1_CHRONIC_LOF_DN,MARKEY_RB1_CHRONIC_LOF_DN,2/18,123/21728,0.004583244939312091,0.048366714241917005,0.02497371855476558,RHOB/HTRA1,2
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,2/18,125/21728,0.004729494342903815,0.04932972587889211,0.02547096096545506,GADD45B/CDKN1A,2
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,3/18,423/21728,0.004809746926193097,0.049590149342473654,0.02560542828221371,KLF9/GADD45B/RHOB,3
REACTOME_CARDIAC_CONDUCTION,REACTOME_CARDIAC_CONDUCTION,2/18,127/21728,0.004877892098976192,0.04972124105433687,0.02567311631040101,ITPR2/KCNE4,2
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,3/18,428/21728,0.004969852436830706,0.05008941163861959,0.025863217885340163,KLF9/GADD45B/RHOB,3
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,2/18,130/21728,0.005104502233811546,0.05031580773328524,0.02598011547573257,CDKN1A/RHOB,2
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,2/18,130/21728,0.005104502233811546,0.05031580773328524,0.02598011547573257,EMP3/HTRA1,2
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,3/18,437/21728,0.005266163521862967,0.05134509433816393,0.026511578370934846,MXRA7/VIM/HTRA1,3
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,3/18,445/21728,0.005538393376795572,0.05341869740844761,0.027582264694850617,GADD45B/RHOB/KCNE4,3
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,2/18,138/21728,0.005732182705125115,0.05469965836699179,0.028243677382475373,GADD45B/RHOB,2
HOLLERN_EMT_BREAST_TUMOR_UP,HOLLERN_EMT_BREAST_TUMOR_UP,2/18,140/21728,0.005894381986047142,0.05565537517351881,0.02873715317297222,VIM/EMP3,2
BOYLAN_MULTIPLE_MYELOMA_C_D_UP,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,2/18,141/21728,0.005976268946947352,0.05584076297303932,0.02883287649843021,KLF9/CDKN1A,2
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,2/18,143/21728,0.006141613383880567,0.05679409490042132,0.029325120877997282,NAGLU/FNDC4,2
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,2/18,145/21728,0.006309046350219886,0.057747087511706506,0.029817190054744893,SCG2/RHOB,2
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,2/18,152/21728,0.0069114140767647355,0.0626216002712926,0.03233410094392859,EMP3/CDKN1A,2
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,2/18,154/21728,0.007088164240626252,0.06358083323841748,0.032829392272374226,GADD45B/CDKN1A,2
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,2/18,156/21728,0.007266966934780571,0.0639065621617468,0.0329975794768158,SCG2/KLF9,2
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,2/18,156/21728,0.007266966934780571,0.0639065621617468,0.0329975794768158,GADD45B/CDKN1A,2
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,3/18,495/21728,0.007433035276477477,0.06473235575728443,0.03342397058405815,MXRA7/RHOB/HTRA1,3
SENGUPTA_EBNA1_ANTICORRELATED,SENGUPTA_EBNA1_ANTICORRELATED,2/18,160/21728,0.00763070392738151,0.06581482137366552,0.03398289198429013,GADD45B/SREBF1,2
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,2/18,166/21728,0.008191541340179197,0.06671451089918207,0.03444743859137489,KLF9/VIM,2
CHEN_HOXA5_TARGETS_6HR_UP,CHEN_HOXA5_TARGETS_6HR_UP,1/18,10/21728,0.008255130223202789,0.06671451089918207,0.03444743859137489,GADD45B,1
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,1/18,10/21728,0.008255130223202789,0.06671451089918207,0.03444743859137489,CDKN1A,1
REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,1/18,10/21728,0.008255130223202789,0.06671451089918207,0.03444743859137489,CDKN1A,1
SHIRAISHI_PLZF_TARGETS_UP,SHIRAISHI_PLZF_TARGETS_UP,1/18,10/21728,0.008255130223202789,0.06671451089918207,0.03444743859137489,KLF9,1
WP_LIVER_X_RECEPTOR_PATHWAY,WP_LIVER_X_RECEPTOR_PATHWAY,1/18,10/21728,0.008255130223202789,0.06671451089918207,0.03444743859137489,SREBF1,1
KIM_WT1_TARGETS_12HR_UP,KIM_WT1_TARGETS_12HR_UP,2/18,167/21728,0.00828678095314236,0.06671451089918207,0.03444743859137489,KLF9/HTRA1,2
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,2/18,168/21728,0.008382523197487944,0.06671451089918207,0.03444743859137489,CDKN1A/HTRA1,2
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,2/18,169/21728,0.008478767271467956,0.06671451089918207,0.03444743859137489,VIM/HTRA1,2
SMID_BREAST_CANCER_LUMINAL_B_UP,SMID_BREAST_CANCER_LUMINAL_B_UP,2/18,169/21728,0.008478767271467956,0.06671451089918207,0.03444743859137489,SREBF1/KCNE4,2
BIOCARTA_EPONFKB_PATHWAY,BIOCARTA_EPONFKB_PATHWAY,1/18,11/21728,0.009077093924095059,0.06829905794109163,0.035265605226873574,CDKN1A,1
IIZUKA_LIVER_CANCER_EARLY_RECURRENCE,IIZUKA_LIVER_CANCER_EARLY_RECURRENCE,1/18,11/21728,0.009077093924095059,0.06829905794109163,0.035265605226873574,VIM,1
REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION,REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION,1/18,11/21728,0.009077093924095059,0.06829905794109163,0.035265605226873574,ITPR2,1
REACTOME_MUCOPOLYSACCHARIDOSES,REACTOME_MUCOPOLYSACCHARIDOSES,1/18,11/21728,0.009077093924095059,0.06829905794109163,0.035265605226873574,NAGLU,1
WHITESIDE_CISPLATIN_RESISTANCE_UP,WHITESIDE_CISPLATIN_RESISTANCE_UP,1/18,11/21728,0.009077093924095059,0.06829905794109163,0.035265605226873574,CDKN1A,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,2/18,179/21728,0.009468632867765446,0.06829905794109163,0.035265605226873574,NAGLU/FNDC4,2
BROWNE_HCMV_INFECTION_48HR_UP,BROWNE_HCMV_INFECTION_48HR_UP,2/18,180/21728,0.00957034439667252,0.06829905794109163,0.035265605226873574,ITPR2/GADD45B,2
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,2/18,182/21728,0.009775243489476823,0.06829905794109163,0.035265605226873574,MXRA7/THBS4,2
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,2/18,182/21728,0.009775243489476823,0.06829905794109163,0.035265605226873574,VIM/RHOB,2
WU_CELL_MIGRATION,WU_CELL_MIGRATION,2/18,183/21728,0.009878429472867193,0.06829905794109163,0.035265605226873574,VIM/EMP3,2
AMIT_EGF_RESPONSE_20_HELA,AMIT_EGF_RESPONSE_20_HELA,1/18,12/21728,0.009898414194361105,0.06829905794109163,0.035265605226873574,GADD45B,1
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,1/18,12/21728,0.009898414194361105,0.06829905794109163,0.035265605226873574,KCNJ8,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,1/18,12/21728,0.009898414194361105,0.06829905794109163,0.035265605226873574,RHOB,1
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,1/18,12/21728,0.009898414194361105,0.06829905794109163,0.035265605226873574,CDKN1A,1
REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS,REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS,1/18,12/21728,0.009898414194361105,0.06829905794109163,0.035265605226873574,VIM,1
WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,1/18,12/21728,0.009898414194361105,0.06829905794109163,0.035265605226873574,CDKN1A,1
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,1/18,13/21728,0.010719091508070266,0.0712224080202891,0.036775050787921384,CDKN1A,1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,1/18,13/21728,0.010719091508070266,0.0712224080202891,0.036775050787921384,CDKN1A,1
TSAI_DNAJB4_TARGETS_UP,TSAI_DNAJB4_TARGETS_UP,1/18,13/21728,0.010719091508070266,0.0712224080202891,0.036775050787921384,CDKN1A,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,1/18,13/21728,0.010719091508070266,0.0712224080202891,0.036775050787921384,VIM,1
WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,1/18,13/21728,0.010719091508070266,0.0712224080202891,0.036775050787921384,SREBF1,1
PLASARI_TGFB1_TARGETS_10HR_UP,PLASARI_TGFB1_TARGETS_10HR_UP,2/18,195/21728,0.01115464911528563,0.07235277600349775,0.03735870614509067,THBS4/GADD45B,2
CASTELLANO_NRAS_TARGETS_DN,CASTELLANO_NRAS_TARGETS_DN,1/18,14/21728,0.011539126338963701,0.07235277600349775,0.03735870614509067,HTRA1,1
FARMER_BREAST_CANCER_CLUSTER_6,FARMER_BREAST_CANCER_CLUSTER_6,1/18,14/21728,0.011539126338963701,0.07235277600349775,0.03735870614509067,RHOB,1
LY_AGING_MIDDLE_UP,LY_AGING_MIDDLE_UP,1/18,14/21728,0.011539126338963701,0.07235277600349775,0.03735870614509067,HTRA1,1
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,1/18,14/21728,0.011539126338963701,0.07235277600349775,0.03735870614509067,CDKN1A,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,1/18,14/21728,0.011539126338963701,0.07235277600349775,0.03735870614509067,CDKN1A,1
VICENT_METASTASIS_UP,VICENT_METASTASIS_UP,1/18,14/21728,0.011539126338963701,0.07235277600349775,0.03735870614509067,MXRA7,1
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,2/18,200/21728,0.011706906222335384,0.07235277600349775,0.03735870614509067,C21orf62/GADD45B,2
IBRAHIM_NRF3_DOWN,IBRAHIM_NRF3_DOWN,1/18,15/21728,0.012358519160456494,0.07235277600349775,0.03735870614509067,CDKN1A,1
LIU_IL13_PRIMING_MODEL,LIU_IL13_PRIMING_MODEL,1/18,15/21728,0.012358519160456494,0.07235277600349775,0.03735870614509067,EMP3,1
NGO_MALIGNANT_GLIOMA_1P_LOH,NGO_MALIGNANT_GLIOMA_1P_LOH,1/18,15/21728,0.012358519160456494,0.07235277600349775,0.03735870614509067,VIM,1
REACTOME_PHASE_2_PLATEAU_PHASE,REACTOME_PHASE_2_PLATEAU_PHASE,1/18,15/21728,0.012358519160456494,0.07235277600349775,0.03735870614509067,KCNE4,1
SA_G1_AND_S_PHASES,SA_G1_AND_S_PHASES,1/18,15/21728,0.012358519160456494,0.07235277600349775,0.03735870614509067,CDKN1A,1
SANCHEZ_MDM2_TARGETS,SANCHEZ_MDM2_TARGETS,1/18,15/21728,0.012358519160456494,0.07235277600349775,0.03735870614509067,CDKN1A,1
SCHAVOLT_TARGETS_OF_TP53_AND_TP63,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,1/18,15/21728,0.012358519160456494,0.07235277600349775,0.03735870614509067,CDKN1A,1
TSUNODA_CISPLATIN_RESISTANCE_UP,TSUNODA_CISPLATIN_RESISTANCE_UP,1/18,15/21728,0.012358519160456494,0.07235277600349775,0.03735870614509067,VIM,1
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,1/18,16/21728,0.013177270445636435,0.07235277600349775,0.03735870614509067,CDKN1A,1
BIOCARTA_P53_PATHWAY,BIOCARTA_P53_PATHWAY,1/18,16/21728,0.013177270445636435,0.07235277600349775,0.03735870614509067,CDKN1A,1
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,1/18,16/21728,0.013177270445636435,0.07235277600349775,0.03735870614509067,VIM,1
INGA_TP53_TARGETS,INGA_TP53_TARGETS,1/18,16/21728,0.013177270445636435,0.07235277600349775,0.03735870614509067,CDKN1A,1
LEE_LIVER_CANCER_HEPATOBLAST,LEE_LIVER_CANCER_HEPATOBLAST,1/18,16/21728,0.013177270445636435,0.07235277600349775,0.03735870614509067,VIM,1
REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,1/18,16/21728,0.013177270445636435,0.07235277600349775,0.03735870614509067,ITPR2,1
REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,1/18,16/21728,0.013177270445636435,0.07235277600349775,0.03735870614509067,CDKN1A,1
WP_ID_SIGNALING_PATHWAY,WP_ID_SIGNALING_PATHWAY,1/18,16/21728,0.013177270445636435,0.07235277600349775,0.03735870614509067,SREBF1,1
HE_PTEN_TARGETS_UP,HE_PTEN_TARGETS_UP,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,CDKN1A,1
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,VIM,1
MATTHEWS_AP1_TARGETS,MATTHEWS_AP1_TARGETS,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,VIM,1
MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA,MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,GADD45B,1
MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS,MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,KLF9,1
PIEPOLI_LGI1_TARGETS_UP,PIEPOLI_LGI1_TARGETS_UP,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,DIRAS3,1
REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,CDKN1A,1
REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,CDKN1A,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,CDKN1A,1
SA_TRKA_RECEPTOR,SA_TRKA_RECEPTOR,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,CDKN1A,1
WP_GLYCOSAMINOGLYCAN_DEGRADATION,WP_GLYCOSAMINOGLYCAN_DEGRADATION,1/18,17/21728,0.013995380667264135,0.07235277600349775,0.03735870614509067,NAGLU,1
BIOCARTA_CALCINEURIN_PATHWAY,BIOCARTA_CALCINEURIN_PATHWAY,1/18,18/21728,0.014812850297773572,0.07235277600349775,0.03735870614509067,CDKN1A,1
CHEN_PDGF_TARGETS,CHEN_PDGF_TARGETS,1/18,18/21728,0.014812850297773572,0.07235277600349775,0.03735870614509067,KLF9,1
KIM_PTEN_TARGETS_UP,KIM_PTEN_TARGETS_UP,1/18,18/21728,0.014812850297773572,0.07235277600349775,0.03735870614509067,CDKN1A,1
ONDER_CDH1_TARGETS_3_UP,ONDER_CDH1_TARGETS_3_UP,1/18,18/21728,0.014812850297773572,0.07235277600349775,0.03735870614509067,KLF9,1
REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,1/18,18/21728,0.014812850297773572,0.07235277600349775,0.03735870614509067,SREBF1,1
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,1/18,18/21728,0.014812850297773572,0.07235277600349775,0.03735870614509067,GADD45B,1
WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,1/18,18/21728,0.014812850297773572,0.07235277600349775,0.03735870614509067,VIM,1
FARMER_BREAST_CANCER_CLUSTER_4,FARMER_BREAST_CANCER_CLUSTER_4,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,HTRA1,1
MANN_RESPONSE_TO_AMIFOSTINE_UP,MANN_RESPONSE_TO_AMIFOSTINE_UP,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,CDKN1A,1
MARSON_FOXP3_CORE_DIRECT_TARGETS,MARSON_FOXP3_CORE_DIRECT_TARGETS,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,GADD45B,1
PHESSE_TARGETS_OF_APC_AND_MBD2_UP,PHESSE_TARGETS_OF_APC_AND_MBD2_UP,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,ITPR2,1
REACTOME_RHO_GTPASES_ACTIVATE_CIT,REACTOME_RHO_GTPASES_ACTIVATE_CIT,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,RHOB,1
REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,RHOB,1
REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,CDKN1A,1
REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION,REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,ITPR2,1
SA_CASPASE_CASCADE,SA_CASPASE_CASCADE,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,SREBF1,1
VERRECCHIA_RESPONSE_TO_TGFB1_C1,VERRECCHIA_RESPONSE_TO_TGFB1_C1,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,RHOB,1
WAGSCHAL_EHMT2_TARGETS_UP,WAGSCHAL_EHMT2_TARGETS_UP,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,CDKN1A,1
WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,1/18,19/21728,0.015629679809272656,0.07235277600349775,0.03735870614509067,SREBF1,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,2/18,238/21728,0.016286573411205114,0.07235277600349775,0.03735870614509067,THBS4/CDKN1A,2
BIOCARTA_ATM_PATHWAY,BIOCARTA_ATM_PATHWAY,1/18,20/21728,0.01644586967354278,0.07235277600349775,0.03735870614509067,CDKN1A,1
DAZARD_UV_RESPONSE_CLUSTER_G28,DAZARD_UV_RESPONSE_CLUSTER_G28,1/18,20/21728,0.01644586967354278,0.07235277600349775,0.03735870614509067,GADD45B,1
DAZARD_UV_RESPONSE_CLUSTER_G4,DAZARD_UV_RESPONSE_CLUSTER_G4,1/18,20/21728,0.01644586967354278,0.07235277600349775,0.03735870614509067,GADD45B,1
FARMER_BREAST_CANCER_CLUSTER_7,FARMER_BREAST_CANCER_CLUSTER_7,1/18,20/21728,0.01644586967354278,0.07235277600349775,0.03735870614509067,SREBF1,1
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,1/18,20/21728,0.01644586967354278,0.07235277600349775,0.03735870614509067,VIM,1
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,1/18,20/21728,0.01644586967354278,0.07235277600349775,0.03735870614509067,HTRA1,1
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,1/18,20/21728,0.01644586967354278,0.07235277600349775,0.03735870614509067,RHOB,1
WP_TP53_NETWORK,WP_TP53_NETWORK,1/18,20/21728,0.01644586967354278,0.07235277600349775,0.03735870614509067,CDKN1A,1
ZHU_SKIL_TARGETS_UP,ZHU_SKIL_TARGETS_UP,1/18,20/21728,0.01644586967354278,0.07235277600349775,0.03735870614509067,CDKN1A,1
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,2/18,240/21728,0.01654588066230913,0.07235277600349775,0.03735870614509067,GADD45B/CDKN1A,2
KAYO_AGING_MUSCLE_UP,KAYO_AGING_MUSCLE_UP,2/18,242/21728,0.016806973144895224,0.07235277600349775,0.03735870614509067,SCG2/CDKN1A,2
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,2/18,243/21728,0.016938186995530975,0.07235277600349775,0.03735870614509067,VIM/CDKN1A,2
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,2/18,245/21728,0.01720194621758325,0.07235277600349775,0.03735870614509067,VIM/CDKN1A,2
BIOCARTA_P53HYPOXIA_PATHWAY,BIOCARTA_P53HYPOXIA_PATHWAY,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,CDKN1A,1
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,CDKN1A,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,CDKN1A,1
KANG_CISPLATIN_RESISTANCE_UP,KANG_CISPLATIN_RESISTANCE_UP,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,CDKN1A,1
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,NAGLU,1
MACLACHLAN_BRCA1_TARGETS_UP,MACLACHLAN_BRCA1_TARGETS_UP,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,CDKN1A,1
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,KLF9,1
OUYANG_PROSTATE_CANCER_MARKERS,OUYANG_PROSTATE_CANCER_MARKERS,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,CDKN1A,1
VANDESLUIS_NORMAL_EMBRYOS_DN,VANDESLUIS_NORMAL_EMBRYOS_DN,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,VIM,1
WP_FOXA2_PATHWAY,WP_FOXA2_PATHWAY,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,SREBF1,1
WP_GALANIN_RECEPTOR_PATHWAY,WP_GALANIN_RECEPTOR_PATHWAY,1/18,21/21728,0.017261420362038482,0.07235277600349775,0.03735870614509067,CDKN1A,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,2/18,250/21728,0.017869077056911604,0.07303815366785736,0.03771259474723611,GADD45B/CDKN1A,2
KANG_FLUOROURACIL_RESISTANCE_UP,KANG_FLUOROURACIL_RESISTANCE_UP,1/18,22/21728,0.018076332345891122,0.07303815366785736,0.03771259474723611,CDKN1A,1
LANDIS_ERBB2_BREAST_TUMORS_65_UP,LANDIS_ERBB2_BREAST_TUMORS_65_UP,1/18,22/21728,0.018076332345891122,0.07303815366785736,0.03771259474723611,ITPR2,1
MURATA_VIRULENCE_OF_H_PILORI,MURATA_VIRULENCE_OF_H_PILORI,1/18,22/21728,0.018076332345891122,0.07303815366785736,0.03771259474723611,CDKN1A,1
REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY,REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY,1/18,22/21728,0.018076332345891122,0.07303815366785736,0.03771259474723611,VIM,1
REACTOME_HS_GAG_DEGRADATION,REACTOME_HS_GAG_DEGRADATION,1/18,22/21728,0.018076332345891122,0.07303815366785736,0.03771259474723611,NAGLU,1
WENG_POR_DOSAGE,WENG_POR_DOSAGE,1/18,22/21728,0.018076332345891122,0.07303815366785736,0.03771259474723611,GADD45B,1
WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,1/18,22/21728,0.018076332345891122,0.07303815366785736,0.03771259474723611,CDKN1A,1
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,2/18,257/21728,0.018821474935331352,0.07303824856907618,0.037712643748628205,KLF9/GADD45B,2
BIOCARTA_CELLCYCLE_PATHWAY,BIOCARTA_CELLCYCLE_PATHWAY,1/18,23/21728,0.01889060609590376,0.07303824856907618,0.037712643748628205,CDKN1A,1
BRACHAT_RESPONSE_TO_CISPLATIN,BRACHAT_RESPONSE_TO_CISPLATIN,1/18,23/21728,0.01889060609590376,0.07303824856907618,0.037712643748628205,CDKN1A,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,1/18,23/21728,0.01889060609590376,0.07303824856907618,0.037712643748628205,CDKN1A,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,1/18,23/21728,0.01889060609590376,0.07303824856907618,0.037712643748628205,RHOB,1
MARKS_HDAC_TARGETS_UP,MARKS_HDAC_TARGETS_UP,1/18,23/21728,0.01889060609590376,0.07303824856907618,0.037712643748628205,GADD45B,1
ONO_FOXP3_TARGETS_UP,ONO_FOXP3_TARGETS_UP,1/18,23/21728,0.01889060609590376,0.07303824856907618,0.037712643748628205,GADD45B,1
PID_PRL_SIGNALING_EVENTS_PATHWAY,PID_PRL_SIGNALING_EVENTS_PATHWAY,1/18,23/21728,0.01889060609590376,0.07303824856907618,0.037712643748628205,CDKN1A,1
REACTOME_RHOBTB1_GTPASE_CYCLE,REACTOME_RHOBTB1_GTPASE_CYCLE,1/18,23/21728,0.01889060609590376,0.07303824856907618,0.037712643748628205,VIM,1
WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,1/18,23/21728,0.01889060609590376,0.07303824856907618,0.037712643748628205,CDKN1A,1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2/18,261/21728,0.019375262320199253,0.07364460478355035,0.0380257303347558,ITPR2/RHOB,2
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,2/18,262/21728,0.019514788256635635,0.07364460478355035,0.0380257303347558,EMP3/HTRA1,2
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,2/18,263/21728,0.019654744379028706,0.07364460478355035,0.0380257303347558,VIM/HTRA1,2
BIOCARTA_G2_PATHWAY,BIOCARTA_G2_PATHWAY,1/18,24/21728,0.01970424208255528,0.07364460478355035,0.0380257303347558,CDKN1A,1
BRACHAT_RESPONSE_TO_METHOTREXATE_UP,BRACHAT_RESPONSE_TO_METHOTREXATE_UP,1/18,24/21728,0.01970424208255528,0.07364460478355035,0.0380257303347558,CDKN1A,1
ONO_AML1_TARGETS_UP,ONO_AML1_TARGETS_UP,1/18,24/21728,0.01970424208255528,0.07364460478355035,0.0380257303347558,GADD45B,1
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,1/18,24/21728,0.01970424208255528,0.07364460478355035,0.0380257303347558,RHOB,1
SHI_SPARC_TARGETS_UP,SHI_SPARC_TARGETS_UP,1/18,24/21728,0.01970424208255528,0.07364460478355035,0.0380257303347558,GADD45B,1
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,1/18,25/21728,0.020517240775999368,0.07592322846635034,0.03920227721081284,HTRA1,1
GENTILE_UV_LOW_DOSE_UP,GENTILE_UV_LOW_DOSE_UP,1/18,25/21728,0.020517240775999368,0.07592322846635034,0.03920227721081284,CDKN1A,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,2/18,271/21728,0.02078979337551904,0.07592322846635034,0.03920227721081284,NAGLU/EMP3,2
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,2/18,274/21728,0.021222447586501467,0.07592322846635034,0.03920227721081284,EMP3/KCNE4,2
BIOCARTA_RACCYCD_PATHWAY,BIOCARTA_RACCYCD_PATHWAY,1/18,26/21728,0.021329602646064982,0.07592322846635034,0.03920227721081284,CDKN1A,1
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,1/18,26/21728,0.021329602646064982,0.07592322846635034,0.03920227721081284,CDKN1A,1
DALESSIO_TSA_RESPONSE,DALESSIO_TSA_RESPONSE,1/18,26/21728,0.021329602646064982,0.07592322846635034,0.03920227721081284,GADD45B,1
GENTILE_UV_RESPONSE_CLUSTER_D9,GENTILE_UV_RESPONSE_CLUSTER_D9,1/18,26/21728,0.021329602646064982,0.07592322846635034,0.03920227721081284,KLF9,1
PID_HDAC_CLASSIII_PATHWAY,PID_HDAC_CLASSIII_PATHWAY,1/18,26/21728,0.021329602646064982,0.07592322846635034,0.03920227721081284,CDKN1A,1
PID_P38_MKK3_6PATHWAY,PID_P38_MKK3_6PATHWAY,1/18,26/21728,0.021329602646064982,0.07592322846635034,0.03920227721081284,GADD45B,1
PID_RXR_VDR_PATHWAY,PID_RXR_VDR_PATHWAY,1/18,26/21728,0.021329602646064982,0.07592322846635034,0.03920227721081284,SREBF1,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,1/18,26/21728,0.021329602646064982,0.07592322846635034,0.03920227721081284,CDKN1A,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,2/18,279/21728,0.0219519595034351,0.07727926599822386,0.03990245501287156,ITPR2/GADD45B,2
NAKAMURA_CANCER_MICROENVIRONMENT_UP,NAKAMURA_CANCER_MICROENVIRONMENT_UP,1/18,27/21728,0.02214132816225589,0.07727926599822386,0.03990245501287156,RHOB,1
NICK_RESPONSE_TO_PROC_TREATMENT_DN,NICK_RESPONSE_TO_PROC_TREATMENT_DN,1/18,27/21728,0.02214132816225589,0.07727926599822386,0.03990245501287156,ITPR2,1
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,1/18,27/21728,0.02214132816225589,0.07727926599822386,0.03990245501287156,ITPR2,1
WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,1/18,27/21728,0.02214132816225589,0.07727926599822386,0.03990245501287156,CDKN1A,1
BIOCARTA_G1_PATHWAY,BIOCARTA_G1_PATHWAY,1/18,28/21728,0.0229524177937509,0.07858136931677312,0.04057478436822176,CDKN1A,1
REACTOME_FLT3_SIGNALING_IN_DISEASE,REACTOME_FLT3_SIGNALING_IN_DISEASE,1/18,28/21728,0.0229524177937509,0.07858136931677312,0.04057478436822176,CDKN1A,1
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,1/18,28/21728,0.0229524177937509,0.07858136931677312,0.04057478436822176,ITPR2,1
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1/18,28/21728,0.0229524177937509,0.07858136931677312,0.04057478436822176,SCG2,1
WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,1/18,28/21728,0.0229524177937509,0.07858136931677312,0.04057478436822176,CDKN1A,1
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,1/18,29/21728,0.023762872009405855,0.08013269245277088,0.041375796138261096,EMP3,1
KRIGE_AMINO_ACID_DEPRIVATION,KRIGE_AMINO_ACID_DEPRIVATION,1/18,29/21728,0.023762872009405855,0.08013269245277088,0.041375796138261096,CDKN1A,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,1/18,29/21728,0.023762872009405855,0.08013269245277088,0.041375796138261096,RHOB,1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,1/18,29/21728,0.023762872009405855,0.08013269245277088,0.041375796138261096,GADD45B,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,1/18,30/21728,0.024572691277751857,0.0816359410227534,0.042151985037858934,SREBF1,1
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,1/18,30/21728,0.024572691277751857,0.0816359410227534,0.042151985037858934,KLF9,1
TING_SILENCED_BY_DICER,TING_SILENCED_BY_DICER,1/18,30/21728,0.024572691277751857,0.0816359410227534,0.042151985037858934,VIM,1
VALK_AML_CLUSTER_12,VALK_AML_CLUSTER_12,1/18,30/21728,0.024572691277751857,0.0816359410227534,0.042151985037858934,MXRA7,1
BURTON_ADIPOGENESIS_1,BURTON_ADIPOGENESIS_1,1/18,31/21728,0.025381876066994713,0.08219329542272295,0.042439769977114475,RHOB,1
DASU_IL6_SIGNALING_SCAR_UP,DASU_IL6_SIGNALING_SCAR_UP,1/18,31/21728,0.025381876066994713,0.08219329542272295,0.042439769977114475,SREBF1,1
HUNSBERGER_EXERCISE_REGULATED_GENES,HUNSBERGER_EXERCISE_REGULATED_GENES,1/18,31/21728,0.025381876066994713,0.08219329542272295,0.042439769977114475,SCG2,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_2,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,1/18,31/21728,0.025381876066994713,0.08219329542272295,0.042439769977114475,GADD45B,1
SIMBULAN_PARP1_TARGETS_UP,SIMBULAN_PARP1_TARGETS_UP,1/18,31/21728,0.025381876066994713,0.08219329542272295,0.042439769977114475,CDKN1A,1
VALK_AML_CLUSTER_15,VALK_AML_CLUSTER_15,1/18,31/21728,0.025381876066994713,0.08219329542272295,0.042439769977114475,KLF9,1
WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE,1/18,31/21728,0.025381876066994713,0.08219329542272295,0.042439769977114475,CDKN1A,1
NOJIMA_SFRP2_TARGETS_UP,NOJIMA_SFRP2_TARGETS_UP,1/18,32/21728,0.026190426845019044,0.08332862002541556,0.043025984640242744,GADD45B,1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,1/18,32/21728,0.026190426845019044,0.08332862002541556,0.043025984640242744,CDKN1A,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,2/18,307/21728,0.02622783985409809,0.08332862002541556,0.043025984640242744,ITPR2/CDKN1A,2
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,2/18,309/21728,0.02654539218584016,0.08332862002541556,0.043025984640242744,DIRAS3/ITPR2,2
DUTTA_APOPTOSIS_VIA_NFKB,DUTTA_APOPTOSIS_VIA_NFKB,1/18,33/21728,0.026998344079384284,0.08332862002541556,0.043025984640242744,GADD45B,1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,1/18,33/21728,0.026998344079384284,0.08332862002541556,0.043025984640242744,GADD45B,1
LIEN_BREAST_CARCINOMA_METAPLASTIC,LIEN_BREAST_CARCINOMA_METAPLASTIC,1/18,33/21728,0.026998344079384284,0.08332862002541556,0.043025984640242744,KCNE4,1
PLASARI_TGFB1_TARGETS_1HR_UP,PLASARI_TGFB1_TARGETS_1HR_UP,1/18,33/21728,0.026998344079384284,0.08332862002541556,0.043025984640242744,GADD45B,1
SIMBULAN_UV_RESPONSE_NORMAL_DN,SIMBULAN_UV_RESPONSE_NORMAL_DN,1/18,33/21728,0.026998344079384284,0.08332862002541556,0.043025984640242744,GADD45B,1
TANG_SENESCENCE_TP53_TARGETS_UP,TANG_SENESCENCE_TP53_TARGETS_UP,1/18,33/21728,0.026998344079384284,0.08332862002541556,0.043025984640242744,CDKN1A,1
WP_WHITE_FAT_CELL_DIFFERENTIATION,WP_WHITE_FAT_CELL_DIFFERENTIATION,1/18,33/21728,0.026998344079384284,0.08332862002541556,0.043025984640242744,SREBF1,1
ZHAN_LATE_DIFFERENTIATION_GENES_UP,ZHAN_LATE_DIFFERENTIATION_GENES_UP,1/18,33/21728,0.026998344079384284,0.08332862002541556,0.043025984640242744,EMP3,1
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,1/18,33/21728,0.026998344079384284,0.08332862002541556,0.043025984640242744,NAGLU,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,2/18,313/21728,0.027185255507565627,0.08332862002541556,0.043025984640242744,NAGLU/THBS4,2
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,2/18,315/21728,0.02750755551688839,0.08332862002541556,0.043025984640242744,VIM/CDKN1A,2
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,1/18,34/21728,0.02780562823732724,0.08332862002541556,0.043025984640242744,HTRA1,1
MURAKAMI_UV_RESPONSE_6HR_UP,MURAKAMI_UV_RESPONSE_6HR_UP,1/18,34/21728,0.02780562823732724,0.08332862002541556,0.043025984640242744,CDKN1A,1
REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,1/18,34/21728,0.02780562823732724,0.08332862002541556,0.043025984640242744,NAGLU,1
REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY,REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY,1/18,34/21728,0.02780562823732724,0.08332862002541556,0.043025984640242744,VIM,1
SCHOEN_NFKB_SIGNALING,SCHOEN_NFKB_SIGNALING,1/18,34/21728,0.02780562823732724,0.08332862002541556,0.043025984640242744,GADD45B,1
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,2/18,317/21728,0.02783142712484323,0.08332862002541556,0.043025984640242744,MXRA7/CDKN1A,2
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,2/18,321/21728,0.028483863307801022,0.08332862002541556,0.043025984640242744,GADD45B/SREBF1,2
ABE_VEGFA_TARGETS_2HR,ABE_VEGFA_TARGETS_2HR,1/18,35/21728,0.02861227978576142,0.08332862002541556,0.043025984640242744,CDKN1A,1
DORSAM_HOXA9_TARGETS_UP,DORSAM_HOXA9_TARGETS_UP,1/18,35/21728,0.02861227978576142,0.08332862002541556,0.043025984640242744,VIM,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,1/18,35/21728,0.02861227978576142,0.08332862002541556,0.043025984640242744,CDKN1A,1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,1/18,35/21728,0.02861227978576142,0.08332862002541556,0.043025984640242744,EMP3,1
PID_PI3KCI_AKT_PATHWAY,PID_PI3KCI_AKT_PATHWAY,1/18,35/21728,0.02861227978576142,0.08332862002541556,0.043025984640242744,CDKN1A,1
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,1/18,35/21728,0.02861227978576142,0.08332862002541556,0.043025984640242744,RHOB,1
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,1/18,35/21728,0.02861227978576142,0.08332862002541556,0.043025984640242744,KCNJ8,1
REACTOME_RHOBTB_GTPASE_CYCLE,REACTOME_RHOBTB_GTPASE_CYCLE,1/18,35/21728,0.02861227978576142,0.08332862002541556,0.043025984640242744,VIM,1
RODRIGUES_NTN1_AND_DCC_TARGETS,RODRIGUES_NTN1_AND_DCC_TARGETS,1/18,35/21728,0.02861227978576142,0.08332862002541556,0.043025984640242744,KLF9,1
CERVERA_SDHB_TARGETS_1_DN,CERVERA_SDHB_TARGETS_1_DN,1/18,36/21728,0.02941829919127703,0.08350700751447943,0.04311809341826081,ITPR2,1
GUTIERREZ_MULTIPLE_MYELOMA_UP,GUTIERREZ_MULTIPLE_MYELOMA_UP,1/18,36/21728,0.02941829919127703,0.08350700751447943,0.04311809341826081,RHOB,1
KIM_ALL_DISORDERS_CALB1_CORR_DN,KIM_ALL_DISORDERS_CALB1_CORR_DN,1/18,36/21728,0.02941829919127703,0.08350700751447943,0.04311809341826081,GADD45B,1
REACTOME_STRIATED_MUSCLE_CONTRACTION,REACTOME_STRIATED_MUSCLE_CONTRACTION,1/18,36/21728,0.02941829919127703,0.08350700751447943,0.04311809341826081,VIM,1
RIZ_ERYTHROID_DIFFERENTIATION_12HR,RIZ_ERYTHROID_DIFFERENTIATION_12HR,1/18,36/21728,0.02941829919127703,0.08350700751447943,0.04311809341826081,KLF9,1
SEMENZA_HIF1_TARGETS,SEMENZA_HIF1_TARGETS,1/18,36/21728,0.02941829919127703,0.08350700751447943,0.04311809341826081,CDKN1A,1
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,1/18,36/21728,0.02941829919127703,0.08350700751447943,0.04311809341826081,ITPR2,1
WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,1/18,36/21728,0.02941829919127703,0.08350700751447943,0.04311809341826081,CDKN1A,1
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,2/18,329/21728,0.029807355411220527,0.08407923837693337,0.04341355968532616,SREBF1/RHOB,2
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,2/18,329/21728,0.029807355411220527,0.08407923837693337,0.04341355968532616,SREBF1/RHOB,2
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,1/18,37/21728,0.0302236869201431,0.08498635475664063,0.043881941081877464,RHOB,1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,2/18,336/21728,0.030985551823012297,0.08511472099131256,0.04394822183439245,VIM/RHOB,2
GRADE_COLON_VS_RECTAL_CANCER_UP,GRADE_COLON_VS_RECTAL_CANCER_UP,1/18,38/21728,0.031028443438304576,0.08511472099131256,0.04394822183439245,GADD45B,1
HUANG_FOXA2_TARGETS_DN,HUANG_FOXA2_TARGETS_DN,1/18,38/21728,0.031028443438304576,0.08511472099131256,0.04394822183439245,CDKN1A,1
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,1/18,38/21728,0.031028443438304576,0.08511472099131256,0.04394822183439245,VIM,1
REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,1/18,38/21728,0.031028443438304576,0.08511472099131256,0.04394822183439245,CDKN1A,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,1/18,38/21728,0.031028443438304576,0.08511472099131256,0.04394822183439245,CDKN1A,1
VALK_AML_CLUSTER_11,VALK_AML_CLUSTER_11,1/18,38/21728,0.031028443438304576,0.08511472099131256,0.04394822183439245,KLF9,1
WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,1/18,38/21728,0.031028443438304576,0.08511472099131256,0.04394822183439245,VIM,1
LANDIS_ERBB2_BREAST_TUMORS_65_DN,LANDIS_ERBB2_BREAST_TUMORS_65_DN,1/18,39/21728,0.03183256921138433,0.08550637882903886,0.04415045084172634,HTRA1,1
NEWMAN_ERCC6_TARGETS_DN,NEWMAN_ERCC6_TARGETS_DN,1/18,39/21728,0.03183256921138433,0.08550637882903886,0.04415045084172634,CDKN1A,1
OLSSON_E2F3_TARGETS_DN,OLSSON_E2F3_TARGETS_DN,1/18,39/21728,0.03183256921138433,0.08550637882903886,0.04415045084172634,VIM,1
ONGUSAHA_TP53_TARGETS,ONGUSAHA_TP53_TARGETS,1/18,39/21728,0.03183256921138433,0.08550637882903886,0.04415045084172634,CDKN1A,1
PID_AURORA_B_PATHWAY,PID_AURORA_B_PATHWAY,1/18,39/21728,0.03183256921138433,0.08550637882903886,0.04415045084172634,VIM,1
WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_HUTCHINSONGILFORD_PROGERIA_SYNDROME,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_HUTCHINSONGILFORD_PROGERIA_SYNDROME,1/18,39/21728,0.03183256921138433,0.08550637882903886,0.04415045084172634,SREBF1,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,2/18,341/21728,0.03183849557290856,0.08550637882903886,0.04415045084172634,GADD45B/CDKN1A,2
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,2/18,345/21728,0.032527611533970095,0.08559809953246401,0.04419781000326723,THBS4/CDKN1A,2
BALDWIN_PRKCI_TARGETS_UP,BALDWIN_PRKCI_TARGETS_UP,1/18,40/21728,0.032636064704685275,0.08559809953246401,0.04419781000326723,RHOB,1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,1/18,40/21728,0.032636064704685275,0.08559809953246401,0.04419781000326723,KLF9,1
KAMMINGA_SENESCENCE,KAMMINGA_SENESCENCE,1/18,40/21728,0.032636064704685275,0.08559809953246401,0.04419781000326723,THBS4,1
WENG_POR_TARGETS_LIVER_UP,WENG_POR_TARGETS_LIVER_UP,1/18,40/21728,0.032636064704685275,0.08559809953246401,0.04419781000326723,GADD45B,1
WP_ATM_SIGNALING_PATHWAY,WP_ATM_SIGNALING_PATHWAY,1/18,40/21728,0.032636064704685275,0.08559809953246401,0.04419781000326723,CDKN1A,1
WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,1/18,40/21728,0.032636064704685275,0.08559809953246401,0.04419781000326723,SREBF1,1
WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,1/18,40/21728,0.032636064704685275,0.08559809953246401,0.04419781000326723,ITPR2,1
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1/18,41/21728,0.03343893038318568,0.08668994379687155,0.044761573984185274,CDKN1A,1
REACTOME_DAG_AND_IP3_SIGNALING,REACTOME_DAG_AND_IP3_SIGNALING,1/18,41/21728,0.03343893038318568,0.08668994379687155,0.044761573984185274,ITPR2,1
WP_BLADDER_CANCER,WP_BLADDER_CANCER,1/18,41/21728,0.03343893038318568,0.08668994379687155,0.044761573984185274,CDKN1A,1
WP_OXIDATIVE_DAMAGE_RESPONSE,WP_OXIDATIVE_DAMAGE_RESPONSE,1/18,41/21728,0.03343893038318568,0.08668994379687155,0.044761573984185274,CDKN1A,1
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,1/18,42/21728,0.03424116671154387,0.08700942362678428,0.04492653452535949,KCNJ8,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1/18,42/21728,0.03424116671154387,0.08700942362678428,0.04492653452535949,GADD45B,1
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,1/18,42/21728,0.03424116671154387,0.08700942362678428,0.04492653452535949,CDKN1A,1
ONO_FOXP3_TARGETS_DN,ONO_FOXP3_TARGETS_DN,1/18,42/21728,0.03424116671154387,0.08700942362678428,0.04492653452535949,CDKN1A,1
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,1/18,42/21728,0.03424116671154387,0.08700942362678428,0.04492653452535949,MXRA7,1
REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,1/18,42/21728,0.03424116671154387,0.08700942362678428,0.04492653452535949,SREBF1,1
REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,1/18,42/21728,0.03424116671154387,0.08700942362678428,0.04492653452535949,ITPR2,1
FUJII_YBX1_TARGETS_UP,FUJII_YBX1_TARGETS_UP,1/18,43/21728,0.03504277415409596,0.08829597869725864,0.045590835682443,CDKN1A,1
KIM_LIVER_CANCER_POOR_SURVIVAL_DN,KIM_LIVER_CANCER_POOR_SURVIVAL_DN,1/18,43/21728,0.03504277415409596,0.08829597869725864,0.045590835682443,ITPR2,1
LASTOWSKA_COAMPLIFIED_WITH_MYCN,LASTOWSKA_COAMPLIFIED_WITH_MYCN,1/18,43/21728,0.03504277415409596,0.08829597869725864,0.045590835682443,FNDC4,1
CORONEL_RFX7_DIRECT_TARGETS_UP,CORONEL_RFX7_DIRECT_TARGETS_UP,1/18,44/21728,0.03584375317485844,0.08907794444731514,0.045994596675255135,KLF9,1
REACTOME_AGGREPHAGY,REACTOME_AGGREPHAGY,1/18,44/21728,0.03584375317485844,0.08907794444731514,0.045994596675255135,VIM,1
WHITFIELD_CELL_CYCLE_LITERATURE,WHITFIELD_CELL_CYCLE_LITERATURE,1/18,44/21728,0.03584375317485844,0.08907794444731514,0.045994596675255135,CDKN1A,1
WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,1/18,44/21728,0.03584375317485844,0.08907794444731514,0.045994596675255135,ITPR2,1
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,2/18,366/21728,0.036242336313237554,0.08907794444731514,0.045994596675255135,EMP3/GADD45B,2
BURTON_ADIPOGENESIS_4,BURTON_ADIPOGENESIS_4,1/18,45/21728,0.03664410423752429,0.08907794444731514,0.045994596675255135,SREBF1,1
CHIBA_RESPONSE_TO_TSA,CHIBA_RESPONSE_TO_TSA,1/18,45/21728,0.03664410423752429,0.08907794444731514,0.045994596675255135,CDKN1A,1
HALMOS_CEBPA_TARGETS_DN,HALMOS_CEBPA_TARGETS_DN,1/18,45/21728,0.03664410423752429,0.08907794444731514,0.045994596675255135,RHOB,1
KERLEY_RESPONSE_TO_CISPLATIN_UP,KERLEY_RESPONSE_TO_CISPLATIN_UP,1/18,45/21728,0.03664410423752429,0.08907794444731514,0.045994596675255135,CDKN1A,1
ROVERSI_GLIOMA_LOH_REGIONS,ROVERSI_GLIOMA_LOH_REGIONS,1/18,45/21728,0.03664410423752429,0.08907794444731514,0.045994596675255135,KCNJ8,1
SIG_CHEMOTAXIS,SIG_CHEMOTAXIS,1/18,45/21728,0.03664410423752429,0.08907794444731514,0.045994596675255135,ITPR2,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,1/18,45/21728,0.03664410423752429,0.08907794444731514,0.045994596675255135,RHOB,1
WP_INTEGRATED_CANCER_PATHWAY,WP_INTEGRATED_CANCER_PATHWAY,1/18,45/21728,0.03664410423752429,0.08907794444731514,0.045994596675255135,CDKN1A,1
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,1/18,46/21728,0.03744382780546818,0.08909048684749325,0.04600107283095351,GADD45B,1
BURTON_ADIPOGENESIS_PEAK_AT_2HR,BURTON_ADIPOGENESIS_PEAK_AT_2HR,1/18,46/21728,0.03744382780546818,0.08909048684749325,0.04600107283095351,RHOB,1
JAEGER_METASTASIS_UP,JAEGER_METASTASIS_UP,1/18,46/21728,0.03744382780546818,0.08909048684749325,0.04600107283095351,THBS4,1
KRASNOSELSKAYA_ILF3_TARGETS_DN,KRASNOSELSKAYA_ILF3_TARGETS_DN,1/18,46/21728,0.03744382780546818,0.08909048684749325,0.04600107283095351,THBS4,1
NUTT_GBM_VS_AO_GLIOMA_UP,NUTT_GBM_VS_AO_GLIOMA_UP,1/18,46/21728,0.03744382780546818,0.08909048684749325,0.04600107283095351,VIM,1
OSADA_ASCL1_TARGETS_UP,OSADA_ASCL1_TARGETS_UP,1/18,46/21728,0.03744382780546818,0.08909048684749325,0.04600107283095351,SCG2,1
SESTO_RESPONSE_TO_UV_C5,SESTO_RESPONSE_TO_UV_C5,1/18,46/21728,0.03744382780546818,0.08909048684749325,0.04600107283095351,SREBF1,1
SIG_BCR_SIGNALING_PATHWAY,SIG_BCR_SIGNALING_PATHWAY,1/18,46/21728,0.03744382780546818,0.08909048684749325,0.04600107283095351,ITPR2,1
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,1/18,47/21728,0.03824292434174237,0.08933308107953881,0.046126334184119086,RHOB,1
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,1/18,47/21728,0.03824292434174237,0.08933308107953881,0.046126334184119086,ITPR2,1
MCDOWELL_ACUTE_LUNG_INJURY_UP,MCDOWELL_ACUTE_LUNG_INJURY_UP,1/18,47/21728,0.03824292434174237,0.08933308107953881,0.046126334184119086,CDKN1A,1
REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,1/18,47/21728,0.03824292434174237,0.08933308107953881,0.046126334184119086,CDKN1A,1
REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,1/18,47/21728,0.03824292434174237,0.08933308107953881,0.046126334184119086,SREBF1,1
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,1/18,47/21728,0.03824292434174237,0.08933308107953881,0.046126334184119086,GADD45B,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,1/18,47/21728,0.03824292434174237,0.08933308107953881,0.046126334184119086,CDKN1A,1
APRELIKOVA_BRCA1_TARGETS,APRELIKOVA_BRCA1_TARGETS,1/18,48/21728,0.03904139430908038,0.09022500341210117,0.046586870270873104,VIM,1
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,1/18,48/21728,0.03904139430908038,0.09022500341210117,0.046586870270873104,EMP3,1
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,1/18,48/21728,0.03904139430908038,0.09022500341210117,0.046586870270873104,CDKN1A,1
WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,1/18,48/21728,0.03904139430908038,0.09022500341210117,0.046586870270873104,SREBF1,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,2/18,382/21728,0.03917919634593792,0.09022500341210117,0.046586870270873104,KLF9/RHOB,2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,2/18,383/21728,0.03936574176044354,0.09022500341210117,0.046586870270873104,CDKN1A/HTRA1,2
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,2/18,384/21728,0.03955263531508675,0.09022500341210117,0.046586870270873104,KLF9/GADD45B,2
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,2/18,384/21728,0.03955263531508675,0.09022500341210117,0.046586870270873104,KLF9/VIM,2
NADLER_OBESITY_DN,NADLER_OBESITY_DN,1/18,49/21728,0.03983923816989354,0.09022500341210117,0.046586870270873104,SREBF1,1
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,1/18,49/21728,0.03983923816989354,0.09022500341210117,0.046586870270873104,CDKN1A,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/18,49/21728,0.03983923816989354,0.09022500341210117,0.046586870270873104,CDKN1A,1
WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,1/18,49/21728,0.03983923816989354,0.09022500341210117,0.046586870270873104,KLF9,1
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,2/18,387/21728,0.04011539849014886,0.09022500341210117,0.046586870270873104,GADD45B/RHOB,2
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,1/18,50/21728,0.04063645638627522,0.09022500341210117,0.046586870270873104,FNDC4,1
OHGUCHI_LIVER_HNF4A_TARGETS_UP,OHGUCHI_LIVER_HNF4A_TARGETS_UP,1/18,50/21728,0.04063645638627522,0.09022500341210117,0.046586870270873104,GADD45B,1
ROY_WOUND_BLOOD_VESSEL_UP,ROY_WOUND_BLOOD_VESSEL_UP,1/18,50/21728,0.04063645638627522,0.09022500341210117,0.046586870270873104,KCNJ8,1
WARTERS_IR_RESPONSE_5GY,WARTERS_IR_RESPONSE_5GY,1/18,50/21728,0.04063645638627522,0.09022500341210117,0.046586870270873104,CDKN1A,1
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,1/18,50/21728,0.04063645638627522,0.09022500341210117,0.046586870270873104,CDKN1A,1
WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,1/18,50/21728,0.04063645638627522,0.09022500341210117,0.046586870270873104,CDKN1A,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,1/18,50/21728,0.04063645638627522,0.09022500341210117,0.046586870270873104,RHOB,1
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,1/18,51/21728,0.04143304941999848,0.09131559049075831,0.047149985115218764,EMP3,1
KOHOUTEK_CCNT1_TARGETS,KOHOUTEK_CCNT1_TARGETS,1/18,51/21728,0.04143304941999848,0.09131559049075831,0.047149985115218764,HTRA1,1
WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,1/18,51/21728,0.04143304941999848,0.09131559049075831,0.047149985115218764,CDKN1A,1
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,1/18,52/21728,0.04222901773251586,0.09210141573711915,0.04755573892428847,SCG2,1
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,1/18,52/21728,0.04222901773251586,0.09210141573711915,0.04755573892428847,MXRA7,1
LUI_THYROID_CANCER_CLUSTER_1,LUI_THYROID_CANCER_CLUSTER_1,1/18,52/21728,0.04222901773251586,0.09210141573711915,0.04755573892428847,MXRA7,1
REACTOME_APOPTOTIC_EXECUTION_PHASE,REACTOME_APOPTOTIC_EXECUTION_PHASE,1/18,52/21728,0.04222901773251586,0.09210141573711915,0.04755573892428847,VIM,1
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,2/18,399/21728,0.042397386470090725,0.09210141573711915,0.04755573892428847,VIM/HTRA1,2
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,2/18,400/21728,0.04258976461416597,0.09210141573711915,0.04755573892428847,KLF9/ITPR2,2
GENTILE_RESPONSE_CLUSTER_D3,GENTILE_RESPONSE_CLUSTER_D3,1/18,53/21728,0.04302436178496172,0.09210141573711915,0.04755573892428847,RHOB,1
HUPER_BREAST_BASAL_VS_LUMINAL_UP,HUPER_BREAST_BASAL_VS_LUMINAL_UP,1/18,53/21728,0.04302436178496172,0.09210141573711915,0.04755573892428847,HTRA1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,1/18,53/21728,0.04302436178496172,0.09210141573711915,0.04755573892428847,MXRA7,1
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SMIRNOV_RESPONSE_TO_IR_2HR_UP,1/18,53/21728,0.04302436178496172,0.09210141573711915,0.04755573892428847,CDKN1A,1
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,1/18,53/21728,0.04302436178496172,0.09210141573711915,0.04755573892428847,CDKN1A,1
BROWNE_HCMV_INFECTION_30MIN_UP,BROWNE_HCMV_INFECTION_30MIN_UP,1/18,54/21728,0.04381908203815055,0.09210141573711915,0.04755573892428847,RHOB,1
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,1/18,54/21728,0.04381908203815055,0.09210141573711915,0.04755573892428847,THBS4,1
MARSON_FOXP3_TARGETS_DN,MARSON_FOXP3_TARGETS_DN,1/18,54/21728,0.04381908203815055,0.09210141573711915,0.04755573892428847,GADD45B,1
PID_TAP63_PATHWAY,PID_TAP63_PATHWAY,1/18,54/21728,0.04381908203815055,0.09210141573711915,0.04755573892428847,CDKN1A,1
REACTOME_G_PROTEIN_MEDIATED_EVENTS,REACTOME_G_PROTEIN_MEDIATED_EVENTS,1/18,54/21728,0.04381908203815055,0.09210141573711915,0.04755573892428847,ITPR2,1
REACTOME_ION_HOMEOSTASIS,REACTOME_ION_HOMEOSTASIS,1/18,54/21728,0.04381908203815055,0.09210141573711915,0.04755573892428847,ITPR2,1
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,1/18,54/21728,0.04381908203815055,0.09210141573711915,0.04755573892428847,RHOB,1
WIERENGA_STAT5A_TARGETS_GROUP2,WIERENGA_STAT5A_TARGETS_GROUP2,1/18,54/21728,0.04381908203815055,0.09210141573711915,0.04755573892428847,GADD45B,1
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,2/18,407/21728,0.04394582601503567,0.09210141573711915,0.04755573892428847,NAGLU/RHOB,2
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,2/18,407/21728,0.04394582601503567,0.09210141573711915,0.04755573892428847,MXRA7/HTRA1,2
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,2/18,408/21728,0.044140886553799975,0.09229458097612722,0.047655478060782706,DIRAS3/CDKN1A,2
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,1/18,55/21728,0.04461317895257888,0.09263430907514643,0.047830893613876,NAGLU,1
REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1/18,55/21728,0.04461317895257888,0.09263430907514643,0.047830893613876,SREBF1,1
RICKMAN_HEAD_AND_NECK_CANCER_F,RICKMAN_HEAD_AND_NECK_CANCER_F,1/18,55/21728,0.04461317895257888,0.09263430907514643,0.047830893613876,THBS4,1
MODY_HIPPOCAMPUS_POSTNATAL,MODY_HIPPOCAMPUS_POSTNATAL,1/18,56/21728,0.045406652988422946,0.09363164995543766,0.048345861621067396,RHOB,1
PETROVA_PROX1_TARGETS_DN,PETROVA_PROX1_TARGETS_DN,1/18,56/21728,0.045406652988422946,0.09363164995543766,0.048345861621067396,EMP3,1
WP_CCL18_SIGNALING_PATHWAY,WP_CCL18_SIGNALING_PATHWAY,1/18,56/21728,0.045406652988422946,0.09363164995543766,0.048345861621067396,VIM,1
BROWNE_HCMV_INFECTION_10HR_DN,BROWNE_HCMV_INFECTION_10HR_DN,1/18,57/21728,0.04619950460554234,0.09439853218945668,0.04874183437582695,KLF9,1
DELASERNA_MYOD_TARGETS_DN,DELASERNA_MYOD_TARGETS_DN,1/18,57/21728,0.04619950460554234,0.09439853218945668,0.04874183437582695,ITPR2,1
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,1/18,57/21728,0.04619950460554234,0.09439853218945668,0.04874183437582695,ITPR2,1
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,1/18,57/21728,0.04619950460554234,0.09439853218945668,0.04874183437582695,HTRA1,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,2/18,421/21728,0.046706709188165656,0.09472266434682874,0.04890919710450584,DIRAS3/CDKN1A,2
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,1/18,58/21728,0.046991734263476914,0.09472266434682874,0.04890919710450584,RHOB,1
KANNAN_TP53_TARGETS_UP,KANNAN_TP53_TARGETS_UP,1/18,58/21728,0.046991734263476914,0.09472266434682874,0.04890919710450584,CDKN1A,1
LEE_EARLY_T_LYMPHOCYTE_DN,LEE_EARLY_T_LYMPHOCYTE_DN,1/18,58/21728,0.046991734263476914,0.09472266434682874,0.04890919710450584,EMP3,1
LIM_MAMMARY_LUMINAL_PROGENITOR_UP,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,1/18,58/21728,0.046991734263476914,0.09472266434682874,0.04890919710450584,ITPR2,1
REACTOME_SIGNALING_BY_PDGF,REACTOME_SIGNALING_BY_PDGF,1/18,58/21728,0.046991734263476914,0.09472266434682874,0.04890919710450584,THBS4,1
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,1/18,59/21728,0.047783342421449104,0.09503693603556508,0.0490714684687539,NAGLU,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1/18,59/21728,0.047783342421449104,0.09503693603556508,0.0490714684687539,CDKN1A,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,1/18,59/21728,0.047783342421449104,0.09503693603556508,0.0490714684687539,GADD45B,1
PID_NOTCH_PATHWAY,PID_NOTCH_PATHWAY,1/18,59/21728,0.047783342421449104,0.09503693603556508,0.0490714684687539,CDKN1A,1
WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,1/18,59/21728,0.047783342421449104,0.09503693603556508,0.0490714684687539,CDKN1A,1
WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,1/18,59/21728,0.047783342421449104,0.09503693603556508,0.0490714684687539,CDKN1A,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,2/18,430/21728,0.04851526081477224,0.09576082108991552,0.049445240015916006,DIRAS3/GADD45B,2
CHANG_IMMORTALIZED_BY_HPV31_DN,CHANG_IMMORTALIZED_BY_HPV31_DN,1/18,60/21728,0.04857432953836294,0.09576082108991552,0.049445240015916006,CDKN1A,1
LEE_LIVER_CANCER_CIPROFIBRATE_UP,LEE_LIVER_CANCER_CIPROFIBRATE_UP,1/18,60/21728,0.04857432953836294,0.09576082108991552,0.049445240015916006,CDKN1A,1
REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1/18,60/21728,0.04857432953836294,0.09576082108991552,0.049445240015916006,CDKN1A,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,2/18,434/21728,0.04932738499740245,0.09689306865931553,0.05002986588053611,GADD45B/CDKN1A,2
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,1/18,61/21728,0.04936469607280625,0.09689306865931553,0.05002986588053611,KLF9,1
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,2/18,438/21728,0.05014457685329605,0.09737778118461768,0.050280142840147604,KLF9/VIM,2
DIRMEIER_LMP1_RESPONSE_EARLY,DIRMEIER_LMP1_RESPONSE_EARLY,1/18,62/21728,0.050154442483047235,0.09737778118461768,0.050280142840147604,GADD45B,1
NAKAMURA_ADIPOGENESIS_EARLY_UP,NAKAMURA_ADIPOGENESIS_EARLY_UP,1/18,62/21728,0.050154442483047235,0.09737778118461768,0.050280142840147604,GADD45B,1
PID_IL12_2PATHWAY,PID_IL12_2PATHWAY,1/18,62/21728,0.050154442483047235,0.09737778118461768,0.050280142840147604,GADD45B,1
REACTOME_CA2_PATHWAY,REACTOME_CA2_PATHWAY,1/18,62/21728,0.050154442483047235,0.09737778118461768,0.050280142840147604,ITPR2,1
LEE_LIVER_CANCER_E2F1_UP,LEE_LIVER_CANCER_E2F1_UP,1/18,63/21728,0.05094356922703802,0.09806090471384786,0.0506328675398616,RHOB,1
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,1/18,63/21728,0.05094356922703802,0.09806090471384786,0.0506328675398616,CDKN1A,1
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,1/18,63/21728,0.05094356922703802,0.09806090471384786,0.0506328675398616,THBS4,1
WP_NOTCH_SIGNALING_PATHWAY,WP_NOTCH_SIGNALING_PATHWAY,1/18,63/21728,0.05094356922703802,0.09806090471384786,0.0506328675398616,CDKN1A,1
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,2/18,445/21728,0.051586741852100784,0.09852159842013745,0.050870742597970406,EMP3/CDKN1A,2
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,2/18,445/21728,0.051586741852100784,0.09852159842013745,0.050870742597970406,MXRA7/C21orf62,2
REACTOME_SEMAPHORIN_INTERACTIONS,REACTOME_SEMAPHORIN_INTERACTIONS,1/18,64/21728,0.051732076762413315,0.09852159842013745,0.050870742597970406,RHOB,1
WP_G1_TO_S_CELL_CYCLE_CONTROL,WP_G1_TO_S_CELL_CYCLE_CONTROL,1/18,64/21728,0.051732076762413315,0.09852159842013745,0.050870742597970406,CDKN1A,1
ZHAN_MULTIPLE_MYELOMA_UP,ZHAN_MULTIPLE_MYELOMA_UP,1/18,64/21728,0.051732076762413315,0.09852159842013745,0.050870742597970406,CDKN1A,1
AMIT_SERUM_RESPONSE_120_MCF10A,AMIT_SERUM_RESPONSE_120_MCF10A,1/18,65/21728,0.052519965546491854,0.09938038094404561,0.05131416724212882,GADD45B,1
KEGG_GLIOMA,KEGG_GLIOMA,1/18,65/21728,0.052519965546491854,0.09938038094404561,0.05131416724212882,CDKN1A,1
PID_RB_1PATHWAY,PID_RB_1PATHWAY,1/18,65/21728,0.052519965546491854,0.09938038094404561,0.05131416724212882,CDKN1A,1
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,2/18,450/21728,0.05262617720002415,0.09938038094404561,0.05131416724212882,VIM/RHOB,2
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,1/18,66/21728,0.05330723603627485,0.10003470862874173,0.05165202346611085,ITPR2,1
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,1/18,66/21728,0.05330723603627485,0.10003470862874173,0.05165202346611085,CDKN1A,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,1/18,66/21728,0.05330723603627485,0.10003470862874173,0.05165202346611085,ITPR2,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,2/18,456/21728,0.053883632133784214,0.10066850239322979,0.05197927718479272,EMP3/HTRA1,2
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,2/18,456/21728,0.053883632133784214,0.10066850239322979,0.05197927718479272,ITPR2/SREBF1,2
MARSON_FOXP3_TARGETS_UP,MARSON_FOXP3_TARGETS_UP,1/18,67/21728,0.05409388868844678,0.10066850239322979,0.05197927718479272,VIM,1
VANHARANTA_UTERINE_FIBROID_DN,VANHARANTA_UTERINE_FIBROID_DN,1/18,67/21728,0.05409388868844678,0.10066850239322979,0.05197927718479272,GADD45B,1
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,1/18,68/21728,0.05487992395937635,0.10077926909948569,0.05203647057885784,CDKN1A,1
DANG_REGULATED_BY_MYC_UP,DANG_REGULATED_BY_MYC_UP,1/18,68/21728,0.05487992395937635,0.10077926909948569,0.05203647057885784,SREBF1,1
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,1/18,68/21728,0.05487992395937635,0.10077926909948569,0.05203647057885784,RHOB,1
REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,1/18,68/21728,0.05487992395937635,0.10077926909948569,0.05203647057885784,CDKN1A,1
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,1/18,68/21728,0.05487992395937635,0.10077926909948569,0.05203647057885784,CDKN1A,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,1/18,68/21728,0.05487992395937635,0.10077926909948569,0.05203647057885784,VIM,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,2/18,461/21728,0.05493986910774638,0.10077926909948569,0.05203647057885784,CDKN1A/RHOB,2
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,2/18,463/21728,0.055364473677825,0.10106140560858837,0.05218214923168325,VIM/CDKN1A,2
ENGELMANN_CANCER_PROGENITORS_DN,ENGELMANN_CANCER_PROGENITORS_DN,1/18,69/21728,0.05566534230511655,0.10106140560858837,0.05218214923168325,GADD45B,1
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,1/18,69/21728,0.05566534230511655,0.10106140560858837,0.05218214923168325,KLF9,1
PID_MTOR_4PATHWAY,PID_MTOR_4PATHWAY,1/18,69/21728,0.05566534230511655,0.10106140560858837,0.05218214923168325,SREBF1,1
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,1/18,70/21728,0.056450144181403594,0.10106140560858837,0.05218214923168325,VIM,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,1/18,70/21728,0.056450144181403594,0.10106140560858837,0.05218214923168325,GADD45B,1
HUANG_DASATINIB_RESISTANCE_DN,HUANG_DASATINIB_RESISTANCE_DN,1/18,70/21728,0.056450144181403594,0.10106140560858837,0.05218214923168325,RHOB,1
KEGG_LONG_TERM_DEPRESSION,KEGG_LONG_TERM_DEPRESSION,1/18,70/21728,0.056450144181403594,0.10106140560858837,0.05218214923168325,ITPR2,1
KEGG_LONG_TERM_POTENTIATION,KEGG_LONG_TERM_POTENTIATION,1/18,70/21728,0.056450144181403594,0.10106140560858837,0.05218214923168325,ITPR2,1
REACTOME_CIRCADIAN_CLOCK,REACTOME_CIRCADIAN_CLOCK,1/18,70/21728,0.056450144181403594,0.10106140560858837,0.05218214923168325,SREBF1,1
REACTOME_RHOB_GTPASE_CYCLE,REACTOME_RHOB_GTPASE_CYCLE,1/18,70/21728,0.056450144181403594,0.10106140560858837,0.05218214923168325,RHOB,1
VERNELL_RETINOBLASTOMA_PATHWAY_UP,VERNELL_RETINOBLASTOMA_PATHWAY_UP,1/18,70/21728,0.056450144181403594,0.10106140560858837,0.05218214923168325,CDKN1A,1
DOANE_BREAST_CANCER_CLASSES_UP,DOANE_BREAST_CANCER_CLASSES_UP,1/18,71/21728,0.05723433004365985,0.10106140560858837,0.05218214923168325,RHOB,1
GU_PDEF_TARGETS_UP,GU_PDEF_TARGETS_UP,1/18,71/21728,0.05723433004365985,0.10106140560858837,0.05218214923168325,VIM,1
KEGG_MELANOMA,KEGG_MELANOMA,1/18,71/21728,0.05723433004365985,0.10106140560858837,0.05218214923168325,CDKN1A,1
LIN_NPAS4_TARGETS_DN,LIN_NPAS4_TARGETS_DN,1/18,71/21728,0.05723433004365985,0.10106140560858837,0.05218214923168325,KLF9,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,1/18,71/21728,0.05723433004365985,0.10106140560858837,0.05218214923168325,GADD45B,1
PEART_HDAC_PROLIFERATION_CLUSTER_DN,PEART_HDAC_PROLIFERATION_CLUSTER_DN,1/18,71/21728,0.05723433004365985,0.10106140560858837,0.05218214923168325,EMP3,1
WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,1/18,71/21728,0.05723433004365985,0.10106140560858837,0.05218214923168325,GADD45B,1
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,2/18,474/21728,0.05772110043047855,0.1017206818981125,0.05252256062332864,NAGLU/CDKN1A,2
LANDIS_BREAST_CANCER_PROGRESSION_DN,LANDIS_BREAST_CANCER_PROGRESSION_DN,1/18,72/21728,0.05801790034698928,0.10184355501222972,0.05258600505237468,HTRA1,1
WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1/18,72/21728,0.05801790034698928,0.10184355501222972,0.05258600505237468,CDKN1A,1
KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_CHRONIC_MYELOID_LEUKEMIA,1/18,73/21728,0.05880085554618364,0.10241624742704218,0.0528817096378555,CDKN1A,1
MCCLUNG_COCAIN_REWARD_4WK,MCCLUNG_COCAIN_REWARD_4WK,1/18,73/21728,0.05880085554618364,0.10241624742704218,0.0528817096378555,ITPR2,1
PID_E2F_PATHWAY,PID_E2F_PATHWAY,1/18,73/21728,0.05880085554618364,0.10241624742704218,0.0528817096378555,CDKN1A,1
WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,1/18,73/21728,0.05880085554618364,0.10241624742704218,0.0528817096378555,SREBF1,1
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,2/18,482/21728,0.05945734744677657,0.10317785115416793,0.053274956882982914,ITPR2/CDKN1A,2
SESTO_RESPONSE_TO_UV_C1,SESTO_RESPONSE_TO_UV_C1,1/18,74/21728,0.05958319609571794,0.10317785115416793,0.053274956882982914,CDKN1A,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,1/18,74/21728,0.05958319609571794,0.10317785115416793,0.053274956882982914,THBS4,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1/18,75/21728,0.060364922449753444,0.10421782616247048,0.053811938639308825,RHOB,1
BRUECKNER_TARGETS_OF_MIRLET7A3_DN,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,1/18,76/21728,0.06114603506213523,0.10421782616247048,0.053811938639308825,VIM,1
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,1/18,76/21728,0.06114603506213523,0.10421782616247048,0.053811938639308825,ITPR2,1
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,1/18,76/21728,0.06114603506213523,0.10421782616247048,0.053811938639308825,CDKN1A,1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,1/18,76/21728,0.06114603506213523,0.10421782616247048,0.053811938639308825,KLF9,1
WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1/18,76/21728,0.06114603506213523,0.10421782616247048,0.053811938639308825,CDKN1A,1
YAMASHITA_LIVER_CANCER_STEM_CELL_DN,YAMASHITA_LIVER_CANCER_STEM_CELL_DN,1/18,76/21728,0.06114603506213523,0.10421782616247048,0.053811938639308825,GADD45B,1
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,2/18,491/21728,0.0614327022463418,0.10421782616247048,0.053811938639308825,MXRA7/KCNJ8,2
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,2/18,493/21728,0.061874805092775154,0.10421782616247048,0.053811938639308825,MXRA7/KLF9,2
MEISSNER_NPC_HCP_WITH_H3K4ME2,MEISSNER_NPC_HCP_WITH_H3K4ME2,2/18,493/21728,0.061874805092775154,0.10421782616247048,0.053811938639308825,MXRA7/KCNJ8,2
CARD_MIR302A_TARGETS,CARD_MIR302A_TARGETS,1/18,77/21728,0.061926534386395504,0.10421782616247048,0.053811938639308825,KLF9,1
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,1/18,77/21728,0.061926534386395504,0.10421782616247048,0.053811938639308825,CDKN1A,1
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1/18,77/21728,0.061926534386395504,0.10421782616247048,0.053811938639308825,RHOB,1
LEE_AGING_NEOCORTEX_UP,LEE_AGING_NEOCORTEX_UP,1/18,77/21728,0.061926534386395504,0.10421782616247048,0.053811938639308825,VIM,1
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,1/18,77/21728,0.061926534386395504,0.10421782616247048,0.053811938639308825,RHOB,1
DUAN_PRDM5_TARGETS,DUAN_PRDM5_TARGETS,1/18,78/21728,0.06270642087575107,0.1047442449265339,0.05408375024077325,GADD45B,1
REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,1/18,78/21728,0.06270642087575107,0.1047442449265339,0.05408375024077325,CDKN1A,1
REACTOME_REGULATION_OF_INSULIN_SECRETION,REACTOME_REGULATION_OF_INSULIN_SECRETION,1/18,78/21728,0.06270642087575107,0.1047442449265339,0.05408375024077325,ITPR2,1
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1/18,78/21728,0.06270642087575107,0.1047442449265339,0.05408375024077325,GADD45B,1
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,2/18,500/21728,0.06343103693291155,0.10506765387425471,0.054250739546643285,VIM/EMP3,2
CORRE_MULTIPLE_MYELOMA_UP,CORRE_MULTIPLE_MYELOMA_UP,1/18,79/21728,0.06348569498310597,0.10506765387425471,0.054250739546643285,SCG2,1
PID_P73PATHWAY,PID_P73PATHWAY,1/18,79/21728,0.06348569498310597,0.10506765387425471,0.054250739546643285,CDKN1A,1
REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1/18,79/21728,0.06348569498310597,0.10506765387425471,0.054250739546643285,CDKN1A,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,1/18,79/21728,0.06348569498310597,0.10506765387425471,0.054250739546643285,EMP3,1
BURTON_ADIPOGENESIS_8,BURTON_ADIPOGENESIS_8,1/18,80/21728,0.06426435716104995,0.10577087774947119,0.05461384287950165,EMP3,1
REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,1/18,80/21728,0.06426435716104995,0.10577087774947119,0.05461384287950165,RHOB,1
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,1/18,80/21728,0.06426435716104995,0.10577087774947119,0.05461384287950165,KLF9,1
FALVELLA_SMOKERS_WITH_LUNG_CANCER,FALVELLA_SMOKERS_WITH_LUNG_CANCER,1/18,81/21728,0.06504240786185844,0.10618777561354793,0.05482910434778043,RHOB,1
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,1/18,81/21728,0.06504240786185844,0.10618777561354793,0.05482910434778043,KLF9,1
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,1/18,81/21728,0.06504240786185844,0.10618777561354793,0.05482910434778043,VIM,1
MORI_PRE_BI_LYMPHOCYTE_UP,MORI_PRE_BI_LYMPHOCYTE_UP,1/18,81/21728,0.06504240786185844,0.10618777561354793,0.05482910434778043,CDKN1A,1
BHAT_ESR1_TARGETS_VIA_AKT1_DN,BHAT_ESR1_TARGETS_VIA_AKT1_DN,1/18,82/21728,0.06581984753749459,0.10618777561354793,0.05482910434778043,KLF9,1
PID_REG_GR_PATHWAY,PID_REG_GR_PATHWAY,1/18,82/21728,0.06581984753749459,0.10618777561354793,0.05482910434778043,CDKN1A,1
PID_SMAD2_3NUCLEAR_PATHWAY,PID_SMAD2_3NUCLEAR_PATHWAY,1/18,82/21728,0.06581984753749459,0.10618777561354793,0.05482910434778043,CDKN1A,1
REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS,REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS,1/18,82/21728,0.06581984753749459,0.10618777561354793,0.05482910434778043,ITPR2,1
REACTOME_SELECTIVE_AUTOPHAGY,REACTOME_SELECTIVE_AUTOPHAGY,1/18,82/21728,0.06581984753749459,0.10618777561354793,0.05482910434778043,VIM,1
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,1/18,82/21728,0.06581984753749459,0.10618777561354793,0.05482910434778043,RHOB,1
WARTERS_RESPONSE_TO_IR_SKIN,WARTERS_RESPONSE_TO_IR_SKIN,1/18,82/21728,0.06581984753749459,0.10618777561354793,0.05482910434778043,CDKN1A,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,1/18,83/21728,0.06659667663960667,0.10629398388919427,0.05488394403713605,VIM,1
NGUYEN_NOTCH1_TARGETS_DN,NGUYEN_NOTCH1_TARGETS_DN,1/18,83/21728,0.06659667663960667,0.10629398388919427,0.05488394403713605,GADD45B,1
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,1/18,83/21728,0.06659667663960667,0.10629398388919427,0.05488394403713605,CDKN1A,1
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,1/18,83/21728,0.06659667663960667,0.10629398388919427,0.05488394403713605,RHOB,1
SWEET_KRAS_TARGETS_UP,SWEET_KRAS_TARGETS_UP,1/18,83/21728,0.06659667663960667,0.10629398388919427,0.05488394403713605,GADD45B,1
WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,1/18,83/21728,0.06659667663960667,0.10629398388919427,0.05488394403713605,CDKN1A,1
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,1/18,84/21728,0.06737289561953241,0.10658463381079467,0.05503401851405229,CDKN1A,1
KEGG_ECM_RECEPTOR_INTERACTION,KEGG_ECM_RECEPTOR_INTERACTION,1/18,84/21728,0.06737289561953241,0.10658463381079467,0.05503401851405229,THBS4,1
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,1/18,84/21728,0.06737289561953241,0.10658463381079467,0.05503401851405229,CDKN1A,1
PID_CMYB_PATHWAY,PID_CMYB_PATHWAY,1/18,84/21728,0.06737289561953241,0.10658463381079467,0.05503401851405229,CDKN1A,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1/18,84/21728,0.06737289561953241,0.10658463381079467,0.05503401851405229,SREBF1,1
KIM_GLIS2_TARGETS_UP,KIM_GLIS2_TARGETS_UP,1/18,85/21728,0.06814850492829427,0.10743270460576444,0.05547191225316712,VIM,1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/18,85/21728,0.06814850492829427,0.10743270460576444,0.05547191225316712,CDKN1A,1
KEGG_TGF_BETA_SIGNALING_PATHWAY,KEGG_TGF_BETA_SIGNALING_PATHWAY,1/18,86/21728,0.06892350501660427,0.10770798606253315,0.05561405136127981,THBS4,1
REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS,REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS,1/18,86/21728,0.06892350501660427,0.10770798606253315,0.05561405136127981,ITPR2,1
REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,1/18,86/21728,0.06892350501660427,0.10770798606253315,0.05561405136127981,ITPR2,1
REACTOME_PLATELET_HOMEOSTASIS,REACTOME_PLATELET_HOMEOSTASIS,1/18,86/21728,0.06892350501660427,0.10770798606253315,0.05561405136127981,ITPR2,1
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1/18,86/21728,0.06892350501660427,0.10770798606253315,0.05561405136127981,RHOB,1
KEGG_ERBB_SIGNALING_PATHWAY,KEGG_ERBB_SIGNALING_PATHWAY,1/18,87/21728,0.06969789633486068,0.10853995314647574,0.056043630093820726,CDKN1A,1
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,1/18,87/21728,0.06969789633486068,0.10853995314647574,0.056043630093820726,CDKN1A,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1/18,88/21728,0.07047167933314913,0.10880051008921647,0.05617816633134454,KLF9,1
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,1/18,88/21728,0.07047167933314913,0.10880051008921647,0.05617816633134454,CDKN1A,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,1/18,88/21728,0.07047167933314913,0.10880051008921647,0.05617816633134454,CDKN1A,1
SASSON_RESPONSE_TO_FORSKOLIN_UP,SASSON_RESPONSE_TO_FORSKOLIN_UP,1/18,88/21728,0.07047167933314913,0.10880051008921647,0.05617816633134454,RHOB,1
WP_RETINOBLASTOMA_GENE_IN_CANCER,WP_RETINOBLASTOMA_GENE_IN_CANCER,1/18,88/21728,0.07047167933314913,0.10880051008921647,0.05617816633134454,CDKN1A,1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,1/18,89/21728,0.07124485446124595,0.10886990536922933,0.056213997960993856,VIM,1
IVANOVSKA_MIR106B_TARGETS,IVANOVSKA_MIR106B_TARGETS,1/18,89/21728,0.07124485446124595,0.10886990536922933,0.056213997960993856,CDKN1A,1
KEGG_PROSTATE_CANCER,KEGG_PROSTATE_CANCER,1/18,89/21728,0.07124485446124595,0.10886990536922933,0.056213997960993856,CDKN1A,1
SAFFORD_T_LYMPHOCYTE_ANERGY,SAFFORD_T_LYMPHOCYTE_ANERGY,1/18,89/21728,0.07124485446124595,0.10886990536922933,0.056213997960993856,GADD45B,1
SWEET_KRAS_ONCOGENIC_SIGNATURE,SWEET_KRAS_ONCOGENIC_SIGNATURE,1/18,89/21728,0.07124485446124595,0.10886990536922933,0.056213997960993856,CDKN1A,1
WP_ALLOGRAFT_REJECTION,WP_ALLOGRAFT_REJECTION,1/18,89/21728,0.07124485446124595,0.10886990536922933,0.056213997960993856,VIM,1
BOYLAN_MULTIPLE_MYELOMA_D_UP,BOYLAN_MULTIPLE_MYELOMA_D_UP,1/18,90/21728,0.07201742216861184,0.10930563060109107,0.056438980771554396,KLF9,1
KEGG_GAP_JUNCTION,KEGG_GAP_JUNCTION,1/18,90/21728,0.07201742216861184,0.10930563060109107,0.056438980771554396,ITPR2,1
REACTOME_OPIOID_SIGNALLING,REACTOME_OPIOID_SIGNALLING,1/18,90/21728,0.07201742216861184,0.10930563060109107,0.056438980771554396,ITPR2,1
UEDA_CENTRAL_CLOCK,UEDA_CENTRAL_CLOCK,1/18,90/21728,0.07201742216861184,0.10930563060109107,0.056438980771554396,GADD45B,1
MORI_IMMATURE_B_LYMPHOCYTE_DN,MORI_IMMATURE_B_LYMPHOCYTE_DN,1/18,91/21728,0.07278938290439896,0.10991932064856207,0.05675585411649042,CDKN1A,1
WP_ERBB_SIGNALING_PATHWAY,WP_ERBB_SIGNALING_PATHWAY,1/18,91/21728,0.07278938290439896,0.10991932064856207,0.05675585411649042,CDKN1A,1
WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,1/18,91/21728,0.07278938290439896,0.10991932064856207,0.05675585411649042,VIM,1
REACTOME_RHO_GTPASES_ACTIVATE_PKNS,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,1/18,92/21728,0.07356073711744704,0.11089744738546217,0.05726090107328916,RHOB,1
SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,1/18,93/21728,0.07433148525628452,0.11187137965585105,0.05776378225497208,MXRA7,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_6,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,1/18,94/21728,0.07510162776912932,0.11284113921090284,0.05826450889256264,EMP3,1
REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,1/18,95/21728,0.0758711651038868,0.1136167530854532,0.05866499015149846,ITPR2,1
WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1/18,95/21728,0.0758711651038868,0.1136167530854532,0.05866499015149846,ITPR2,1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,1/18,96/21728,0.07664009770815527,0.11419629176779947,0.05896422974573933,NAGLU,1
GUO_TARGETS_OF_IRS1_AND_IRS2,GUO_TARGETS_OF_IRS1_AND_IRS2,1/18,96/21728,0.07664009770815527,0.11419629176779947,0.05896422974573933,KLF9,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1/18,96/21728,0.07664009770815527,0.11419629176779947,0.05896422974573933,CDKN1A,1
PID_CXCR4_PATHWAY,PID_CXCR4_PATHWAY,1/18,100/21728,0.07970978976139287,0.11837695598670431,0.061122878171859296,RHOB,1
REACTOME_CLEC7A_DECTIN_1_SIGNALING,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1/18,100/21728,0.07970978976139287,0.11837695598670431,0.061122878171859296,ITPR2,1
GAVIN_FOXP3_TARGETS_CLUSTER_P4,GAVIN_FOXP3_TARGETS_CLUSTER_P4,1/18,101/21728,0.080475705416298,0.11892373601057547,0.061405203126976726,GADD45B,1
GAVIN_FOXP3_TARGETS_CLUSTER_T7,GAVIN_FOXP3_TARGETS_CLUSTER_T7,1/18,101/21728,0.080475705416298,0.11892373601057547,0.061405203126976726,VIM,1
KEGG_GNRH_SIGNALING_PATHWAY,KEGG_GNRH_SIGNALING_PATHWAY,1/18,101/21728,0.080475705416298,0.11892373601057547,0.061405203126976726,ITPR2,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,1/18,102/21728,0.0812410190197802,0.11966041717691765,0.06178558183165379,HTRA1,1
WP_NEURAL_CREST_DIFFERENTIATION,WP_NEURAL_CREST_DIFFERENTIATION,1/18,102/21728,0.0812410190197802,0.11966041717691765,0.06178558183165379,RHOB,1
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,1/18,103/21728,0.08200573101726694,0.12039139234449826,0.06216301429511147,GADD45B,1
REACTOME_POTASSIUM_CHANNELS,REACTOME_POTASSIUM_CHANNELS,1/18,103/21728,0.08200573101726694,0.12039139234449826,0.06216301429511147,KCNJ8,1
GHANDHI_DIRECT_IRRADIATION_UP,GHANDHI_DIRECT_IRRADIATION_UP,1/18,105/21728,0.08353335197442002,0.12163866350820579,0.06280703155971432,CDKN1A,1
LE_EGR2_TARGETS_DN,LE_EGR2_TARGETS_DN,1/18,105/21728,0.08353335197442002,0.12163866350820579,0.06280703155971432,CDKN1A,1
LEIN_CHOROID_PLEXUS_MARKERS,LEIN_CHOROID_PLEXUS_MARKERS,1/18,105/21728,0.08353335197442002,0.12163866350820579,0.06280703155971432,C21orf62,1
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1/18,105/21728,0.08353335197442002,0.12163866350820579,0.06280703155971432,CDKN1A,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,1/18,105/21728,0.08353335197442002,0.12163866350820579,0.06280703155971432,RHOB,1
BROWNE_HCMV_INFECTION_8HR_UP,BROWNE_HCMV_INFECTION_8HR_UP,1/18,106/21728,0.08429626182339867,0.12215467989594282,0.06307347198757829,RHOB,1
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,1/18,106/21728,0.08429626182339867,0.12215467989594282,0.06307347198757829,VIM,1
REACTOME_SIGNALING_BY_VEGF,REACTOME_SIGNALING_BY_VEGF,1/18,106/21728,0.08429626182339867,0.12215467989594282,0.06307347198757829,ITPR2,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,1/18,107/21728,0.0850585718450051,0.12286238155389624,0.06343888738334139,KCNE4,1
TAVAZOIE_METASTASIS,TAVAZOIE_METASTASIS,1/18,107/21728,0.0850585718450051,0.12286238155389624,0.06343888738334139,KLF9,1
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,1/18,108/21728,0.0858202824831249,0.12336665606949204,0.06369926500096991,ITPR2,1
BOUDOUKHA_BOUND_BY_IGF2BP2,BOUDOUKHA_BOUND_BY_IGF2BP2,1/18,108/21728,0.0858202824831249,0.12336665606949204,0.06369926500096991,KLF9,1
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,1/18,108/21728,0.0858202824831249,0.12336665606949204,0.06369926500096991,ITPR2,1
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,1/18,109/21728,0.08658139418133493,0.1240631159435422,0.0640588758025683,VIM,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1/18,109/21728,0.08658139418133493,0.1240631159435422,0.0640588758025683,KLF9,1
REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,1/18,110/21728,0.08734190738290493,0.1247542849083849,0.06441575469071098,CDKN1A,1
WP_BURN_WOUND_HEALING,WP_BURN_WOUND_HEALING,1/18,110/21728,0.08734190738290493,0.1247542849083849,0.06441575469071098,VIM,1
MARKEY_RB1_CHRONIC_LOF_UP,MARKEY_RB1_CHRONIC_LOF_UP,1/18,112/21728,0.08886114006766266,0.12612095354540095,0.06512142176844032,CDKN1A,1
PASINI_SUZ12_TARGETS_UP,PASINI_SUZ12_TARGETS_UP,1/18,112/21728,0.08886114006766266,0.12612095354540095,0.06512142176844032,HTRA1,1
ROPERO_HDAC2_TARGETS,ROPERO_HDAC2_TARGETS,1/18,112/21728,0.08886114006766266,0.12612095354540095,0.06512142176844032,EMP3,1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,1/18,112/21728,0.08886114006766266,0.12612095354540095,0.06512142176844032,KLF9,1
DITTMER_PTHLH_TARGETS_UP,DITTMER_PTHLH_TARGETS_UP,1/18,113/21728,0.08961986043585213,0.12659687371804623,0.06536715887571477,KLF9,1
KEGG_OOCYTE_MEIOSIS,KEGG_OOCYTE_MEIOSIS,1/18,113/21728,0.08961986043585213,0.12659687371804623,0.06536715887571477,ITPR2,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,1/18,113/21728,0.08961986043585213,0.12659687371804623,0.06536715887571477,CDKN1A,1
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,1/18,114/21728,0.0903779840774045,0.1274670624487922,0.06581647301234357,CDKN1A,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,1/18,115/21728,0.09113551143405296,0.12793200900836543,0.06605654399305379,KLF9,1
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,1/18,115/21728,0.09113551143405296,0.12793200900836543,0.06605654399305379,ITPR2,1
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,1/18,115/21728,0.09113551143405296,0.12793200900836543,0.06605654399305379,EMP3,1
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,1/18,116/21728,0.0918924429472252,0.12879300206822034,0.0665011100275972,ITPR2,1
DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,1/18,117/21728,0.09264877905804081,0.1296504755305189,0.06694385874954917,GADD45B,1
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1/18,120/21728,0.09491421938296363,0.13240755021231473,0.06836744950233936,SREBF1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1/18,120/21728,0.09491421938296363,0.13240755021231473,0.06836744950233936,CDKN1A,1
CERVERA_SDHB_TARGETS_1_UP,CERVERA_SDHB_TARGETS_1_UP,1/18,121/21728,0.09566817828943863,0.13304551306298673,0.06869685589123298,HTRA1,1
KEGG_LYSOSOME,KEGG_LYSOSOME,1/18,121/21728,0.09566817828943863,0.13304551306298673,0.06869685589123298,NAGLU,1
LEE_NEURAL_CREST_STEM_CELL_DN,LEE_NEURAL_CREST_STEM_CELL_DN,1/18,122/21728,0.09642154399457037,0.1338856423577858,0.0691306491080511,HTRA1,1
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,1/18,123/21728,0.09717431693764667,0.13472235284863843,0.06956267705615314,RHOB,1
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1/18,124/21728,0.09792649755764737,0.13534679246411355,0.06988510084399456,NAGLU,1
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1/18,124/21728,0.09792649755764737,0.13534679246411355,0.06988510084399456,SCG2,1
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,1/18,125/21728,0.09867808629325048,0.13575804203227865,0.07009744586540234,EMP3,1
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,1/18,125/21728,0.09867808629325048,0.13575804203227865,0.07009744586540234,CDKN1A,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,1/18,125/21728,0.09867808629325048,0.13575804203227865,0.07009744586540234,CDKN1A,1
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,1/18,126/21728,0.09942908358282665,0.13637291739112464,0.0704149312352225,EMP3,1
INGRAM_SHH_TARGETS_UP,INGRAM_SHH_TARGETS_UP,1/18,126/21728,0.09942908358282665,0.13637291739112464,0.0704149312352225,KLF9,1
MATTIOLI_MGUS_VS_PCL,MATTIOLI_MGUS_VS_PCL,1/18,127/21728,0.10017948986444425,0.13698323537866844,0.07073006344729697,GADD45B,1
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,1/18,127/21728,0.10017948986444425,0.13698323537866844,0.07073006344729697,HTRA1,1
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/18,128/21728,0.10092930557586721,0.1377984582976452,0.07115099648062416,FNDC4,1
MIKKELSEN_MEF_LCP_WITH_H3K4ME3,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,1/18,129/21728,0.10167853115455416,0.13861039885354876,0.07157023469525489,EMP3,1
BROWN_MYELOID_CELL_DEVELOPMENT_DN,BROWN_MYELOID_CELL_DEVELOPMENT_DN,1/18,131/21728,0.10317521366203919,0.1398008559740924,0.07218491653887303,C21orf62,1
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,1/18,131/21728,0.10317521366203919,0.1398008559740924,0.07218491653887303,GADD45B,1
WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,1/18,131/21728,0.10317521366203919,0.1398008559740924,0.07218491653887303,SREBF1,1
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,1/18,131/21728,0.10317521366203919,0.1398008559740924,0.07218491653887303,RHOB,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,1/18,132/21728,0.10392267146423728,0.14038951250515186,0.07248886405241663,KCNJ8,1
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,1/18,132/21728,0.10392267146423728,0.14038951250515186,0.07248886405241663,SREBF1,1
QI_HYPOXIA,QI_HYPOXIA,1/18,133/21728,0.10466954088050162,0.14097384109581074,0.07279057687280026,CDKN1A,1
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,1/18,133/21728,0.10466954088050162,0.14097384109581074,0.07279057687280026,CDKN1A,1
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,1/18,134/21728,0.10541582234677449,0.1415538812051747,0.0730900753743788,EMP3,1
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,1/18,134/21728,0.10541582234677449,0.1415538812051747,0.0730900753743788,RHOB,1
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,1/18,135/21728,0.10616151629869386,0.14234212275026667,0.07349707681759941,GADD45B,1
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1/18,136/21728,0.10690662317159849,0.14291392099094463,0.07379231970429577,CDKN1A,1
UDAYAKUMAR_MED1_TARGETS_UP,UDAYAKUMAR_MED1_TARGETS_UP,1/18,136/21728,0.10690662317159849,0.14291392099094463,0.07379231970429577,NAGLU,1
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,1/18,137/21728,0.10765114340052162,0.14326865820514526,0.07397548507922773,SREBF1,1
LI_INDUCED_T_TO_NATURAL_KILLER_DN,LI_INDUCED_T_TO_NATURAL_KILLER_DN,1/18,137/21728,0.10765114340052162,0.14326865820514526,0.07397548507922773,ITPR2,1
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,1/18,137/21728,0.10765114340052162,0.14326865820514526,0.07397548507922773,CDKN1A,1
CHUNG_BLISTER_CYTOTOXICITY_UP,CHUNG_BLISTER_CYTOTOXICITY_UP,1/18,138/21728,0.10839507742019616,0.14383192965372182,0.07426632523339508,CDKN1A,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,1/18,138/21728,0.10839507742019616,0.14383192965372182,0.07426632523339508,GADD45B,1
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,1/18,140/21728,0.10988118856921747,0.14452115270760713,0.07462219936788964,THBS4,1
HOELZEL_NF1_TARGETS_UP,HOELZEL_NF1_TARGETS_UP,1/18,140/21728,0.10988118856921747,0.14452115270760713,0.07462219936788964,SCG2,1
ONDER_CDH1_TARGETS_1_UP,ONDER_CDH1_TARGETS_1_UP,1/18,140/21728,0.10988118856921747,0.14452115270760713,0.07462219936788964,KLF9,1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1/18,140/21728,0.10988118856921747,0.14452115270760713,0.07462219936788964,ITPR2,1
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1/18,140/21728,0.10988118856921747,0.14452115270760713,0.07462219936788964,HTRA1,1
REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,1/18,140/21728,0.10988118856921747,0.14452115270760713,0.07462219936788964,RHOB,1
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,1/18,141/21728,0.11062336656651939,0.1452842749782839,0.07501623069934273,RHOB,1
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/18,143/21728,0.11210596957433216,0.14680153971996487,0.07579965672332871,CDKN1A,1
REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1/18,143/21728,0.11210596957433216,0.14680153971996487,0.07579965672332871,ITPR2,1
BROWNE_HCMV_INFECTION_24HR_DN,BROWNE_HCMV_INFECTION_24HR_DN,1/18,145/21728,0.11358623815307878,0.14809135991760417,0.07646564379950224,CDKN1A,1
KIM_ALL_DISORDERS_DURATION_CORR_DN,KIM_ALL_DISORDERS_DURATION_CORR_DN,1/18,145/21728,0.11358623815307878,0.14809135991760417,0.07646564379950224,FNDC4,1
MIKKELSEN_ES_LCP_WITH_H3K4ME3,MIKKELSEN_ES_LCP_WITH_H3K4ME3,1/18,145/21728,0.11358623815307878,0.14809135991760417,0.07646564379950224,EMP3,1
BASSO_B_LYMPHOCYTE_NETWORK,BASSO_B_LYMPHOCYTE_NETWORK,1/18,146/21728,0.11432549811291959,0.14819360087758507,0.07651843500104141,ITPR2,1
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1/18,146/21728,0.11432549811291959,0.14819360087758507,0.07651843500104141,GADD45B,1
REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1/18,146/21728,0.11432549811291959,0.14819360087758507,0.07651843500104141,ITPR2,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1/18,146/21728,0.11432549811291959,0.14819360087758507,0.07651843500104141,KCNE4,1
KATSANOU_ELAVL1_TARGETS_DN,KATSANOU_ELAVL1_TARGETS_DN,1/18,147/21728,0.1150641757625338,0.1487212761656957,0.07679089539741374,THBS4,1
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,1/18,147/21728,0.1150641757625338,0.1487212761656957,0.07679089539741374,RHOB,1
RODWELL_AGING_KIDNEY_DN,RODWELL_AGING_KIDNEY_DN,1/18,148/21728,0.11580227153364164,0.14903104385319446,0.07695084116106975,KLF9,1
RODWELL_AGING_KIDNEY_NO_BLOOD_DN,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,1/18,148/21728,0.11580227153364164,0.14903104385319446,0.07695084116106975,KLF9,1
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,1/18,148/21728,0.11580227153364164,0.14903104385319446,0.07695084116106975,GADD45B,1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1/18,149/21728,0.11653978585766311,0.14955105567142177,0.0772193445935875,CDKN1A,1
VANTVEER_BREAST_CANCER_ESR1_UP,VANTVEER_BREAST_CANCER_ESR1_UP,1/18,149/21728,0.11653978585766311,0.14955105567142177,0.0772193445935875,SREBF1,1
GOLDRATH_HOMEOSTATIC_PROLIFERATION,GOLDRATH_HOMEOSTATIC_PROLIFERATION,1/18,150/21728,0.11727671916572024,0.14985358560064252,0.07737555320575334,KLF9,1
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,1/18,150/21728,0.11727671916572024,0.14985358560064252,0.07737555320575334,CDKN1A,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,1/18,150/21728,0.11727671916572024,0.14985358560064252,0.07737555320575334,VIM,1
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1/18,151/21728,0.11801307188863308,0.15036608733537482,0.07764017887410071,ITPR2,1
REACTOME_AUTOPHAGY,REACTOME_AUTOPHAGY,1/18,151/21728,0.11801307188863308,0.15036608733537482,0.07764017887410071,VIM,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1/18,152/21728,0.11874884445692391,0.1504487478500858,0.07768285988856159,EMP3,1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,1/18,152/21728,0.11874884445692391,0.1504487478500858,0.07768285988856159,CDKN1A,1
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1/18,152/21728,0.11874884445692391,0.1504487478500858,0.07768285988856159,HTRA1,1
WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,1/18,152/21728,0.11874884445692391,0.1504487478500858,0.07768285988856159,ITPR2,1
REACTOME_METABOLISM_OF_STEROIDS,REACTOME_METABOLISM_OF_STEROIDS,1/18,153/21728,0.11948403730081425,0.15116668753008516,0.07805356159506834,SREBF1,1
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,1/18,154/21728,0.12021865085022687,0.15188187297556832,0.07842284117731628,CDKN1A,1
WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,1/18,158/21728,0.12315132069111023,0.15536812188456522,0.08022293449417205,ITPR2,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1/18,159/21728,0.12388304420652785,0.15585286206627696,0.08047322573392228,KLF9,1
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,1/18,159/21728,0.12388304420652785,0.15585286206627696,0.08047322573392228,CDKN1A,1
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,1/18,160/21728,0.12461419100073623,0.15633416689183274,0.08072174315837165,NAGLU,1
WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,1/18,160/21728,0.12461419100073623,0.15633416689183274,0.08072174315837165,SREBF1,1
REACTOME_S_PHASE,REACTOME_S_PHASE,1/18,162/21728,0.1260747561365666,0.15772532253068375,0.08144005387959966,CDKN1A,1
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1/18,162/21728,0.1260747561365666,0.15772532253068375,0.08144005387959966,KCNJ8,1
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,1/18,163/21728,0.12680417533296617,0.15841691542293965,0.08179715165885518,EMP3,1
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,1/18,164/21728,0.1275330195177099,0.1588848868158136,0.08203878448507655,EMP3,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,1/18,164/21728,0.1275330195177099,0.1588848868158136,0.08203878448507655,CDKN1A,1
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,1/18,166/21728,0.12898898455851926,0.16003197669293467,0.08263107404200112,RHOB,1
KEGG_ALZHEIMERS_DISEASE,KEGG_ALZHEIMERS_DISEASE,1/18,166/21728,0.12898898455851926,0.16003197669293467,0.08263107404200112,ITPR2,1
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1/18,166/21728,0.12898898455851926,0.16003197669293467,0.08263107404200112,ITPR2,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1/18,168/21728,0.13044265466859917,0.16138904998308062,0.08333178664854249,KCNJ8,1
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,1/18,168/21728,0.13044265466859917,0.16138904998308062,0.08333178664854249,CDKN1A,1
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,1/18,170/21728,0.13189403325281202,0.16295998323384625,0.08414292392523894,THBS4,1
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,1/18,171/21728,0.13261886428544267,0.1636301530454499,0.08448896008918379,KLF9,1
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,1/18,172/21728,0.13334312371128432,0.16429777742997534,0.0848336819447153,GADD45B,1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1/18,173/21728,0.13406681195461267,0.16451153258999668,0.08494405250202258,MXRA7,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,1/18,173/21728,0.13406681195461267,0.16451153258999668,0.08494405250202258,MXRA7,1
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,1/18,173/21728,0.13406681195461267,0.16451153258999668,0.08494405250202258,GADD45B,1
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,1/18,174/21728,0.13478992943941037,0.16494756713117475,0.08516919502167095,C21orf62,1
MIKKELSEN_IPS_LCP_WITH_H3K4ME3,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,1/18,174/21728,0.13478992943941037,0.16494756713117475,0.08516919502167095,EMP3,1
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,1/18,177/21728,0.13695586157800743,0.16736976544342325,0.08641987536831101,THBS4,1
KEGG_CALCIUM_SIGNALING_PATHWAY,KEGG_CALCIUM_SIGNALING_PATHWAY,1/18,178/21728,0.13767670026259726,0.16779347844504042,0.08663865577165733,ITPR2,1
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,1/18,178/21728,0.13767670026259726,0.16779347844504042,0.08663865577165733,CDKN1A,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,1/18,179/21728,0.13839697030414144,0.16821420374365156,0.08685589350138674,EMP3,1
REACTOME_APOPTOSIS,REACTOME_APOPTOSIS,1/18,179/21728,0.13839697030414144,0.16821420374365156,0.08685589350138674,VIM,1
DOANE_RESPONSE_TO_ANDROGEN_UP,DOANE_RESPONSE_TO_ANDROGEN_UP,1/18,184/21728,0.1419898056333796,0.17234757192576655,0.08899012104363939,GADD45B,1
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1/18,186/21728,0.1434229740186299,0.173383298779934,0.089524909303727,ITPR2,1
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,1/18,186/21728,0.1434229740186299,0.173383298779934,0.089524909303727,CDKN1A,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,1/18,186/21728,0.1434229740186299,0.173383298779934,0.089524909303727,CDKN1A,1
JISON_SICKLE_CELL_DISEASE_DN,JISON_SICKLE_CELL_DISEASE_DN,1/18,187/21728,0.14413871009084522,0.17378013837565612,0.08972981386526868,KLF9,1
LEE_LIVER_CANCER_SURVIVAL_UP,LEE_LIVER_CANCER_SURVIVAL_UP,1/18,187/21728,0.14413871009084522,0.17378013837565612,0.08972981386526868,ITPR2,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,1/18,190/21728,0.14628253086339227,0.17612809420733272,0.09094215977377973,C21orf62,1
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,1/18,194/21728,0.1491330701689666,0.17907946980128922,0.0924660760576979,CDKN1A,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,1/18,194/21728,0.1491330701689666,0.17907946980128922,0.0924660760576979,HTRA1,1
NABA_ECM_GLYCOPROTEINS,NABA_ECM_GLYCOPROTEINS,1/18,196/21728,0.15055496661272294,0.18030414559627833,0.09309842640657451,THBS4,1
REACTOME_CELLULAR_SENESCENCE,REACTOME_CELLULAR_SENESCENCE,1/18,196/21728,0.15055496661272294,0.18030414559627833,0.09309842640657451,CDKN1A,1
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,1/18,197/21728,0.15126507299396807,0.18091302730078582,0.09341281700680136,CDKN1A,1
WHITFIELD_CELL_CYCLE_G2_M,WHITFIELD_CELL_CYCLE_G2_M,1/18,198/21728,0.15197461870415796,0.18151961781308878,0.0937260245705088,KLF9,1
AFFAR_YY1_TARGETS_UP,AFFAR_YY1_TARGETS_UP,1/18,199/21728,0.15268360415995563,0.18164083943167136,0.09378861626466631,CDKN1A,1
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,1/18,199/21728,0.15268360415995563,0.18164083943167136,0.09378861626466631,THBS4,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,1/18,199/21728,0.15268360415995563,0.18164083943167136,0.09378861626466631,HTRA1,1
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,1/18,200/21728,0.15339202977773292,0.18200086072834185,0.09397451002812934,GADD45B,1
REACTOME_MITOTIC_G2_G2_M_PHASES,REACTOME_MITOTIC_G2_G2_M_PHASES,1/18,200/21728,0.15339202977773292,0.18200086072834185,0.09397451002812934,CDKN1A,1
WELCSH_BRCA1_TARGETS_UP,WELCSH_BRCA1_TARGETS_UP,1/18,201/21728,0.15409989597357066,0.18235832016925183,0.09415908100037645,CDKN1A,1
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,1/18,201/21728,0.15409989597357066,0.18235832016925183,0.09415908100037645,GADD45B,1
KIM_MYC_AMPLIFICATION_TARGETS_UP,KIM_MYC_AMPLIFICATION_TARGETS_UP,1/18,202/21728,0.1548072031632618,0.18247314223054642,0.09421836834059782,RHOB,1
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,1/18,202/21728,0.1548072031632618,0.18247314223054642,0.09421836834059782,KLF9,1
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,1/18,202/21728,0.1548072031632618,0.18247314223054642,0.09421836834059782,THBS4,1
HOLLMANN_APOPTOSIS_VIA_CD40_UP,HOLLMANN_APOPTOSIS_VIA_CD40_UP,1/18,203/21728,0.1555139517623073,0.18306563612964522,0.09452429724466807,EMP3,1
PAL_PRMT5_TARGETS_UP,PAL_PRMT5_TARGETS_UP,1/18,204/21728,0.15622014218592084,0.18365592076116777,0.09482908541326507,EMP3,1
SHEPARD_CRASH_AND_BURN_MUTANT_UP,SHEPARD_CRASH_AND_BURN_MUTANT_UP,1/18,205/21728,0.15692577484902548,0.18424400528740295,0.09513273757725436,GADD45B,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/18,207/21728,0.15833536855195263,0.18517187169635138,0.09561183306506438,CDKN1A,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,1/18,207/21728,0.15833536855195263,0.18517187169635138,0.09561183306506438,RHOB,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,1/18,207/21728,0.15833536855195263,0.18517187169635138,0.09561183306506438,HTRA1,1
MIKKELSEN_MEF_ICP_WITH_H3K27ME3,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,1/18,208/21728,0.15903933042017748,0.18551141662795737,0.09578715404130875,C21orf62,1
REACTOME_PROGRAMMED_CELL_DEATH,REACTOME_PROGRAMMED_CELL_DEATH,1/18,208/21728,0.15903933042017748,0.18551141662795737,0.09578715404130875,VIM,1
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/18,210/21728,0.16044558625898675,0.1869086894471573,0.09650862331367624,CDKN1A,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,1/18,214/21728,0.16325143791338226,0.18993066122996613,0.09806899130573855,HTRA1,1
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,1/18,216/21728,0.16465104032850886,0.19081651572955097,0.09852639432142514,KLF9,1
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1/18,216/21728,0.16465104032850886,0.19081651572955097,0.09852639432142514,ITPR2,1
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,1/18,216/21728,0.16465104032850886,0.19081651572955097,0.09852639432142514,EMP3,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,1/18,217/21728,0.165350012124441,0.19137930435564335,0.09881698517453862,GADD45B,1
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,1/18,219/21728,0.16674629894893467,0.1924986231109323,0.09939493536209612,CDKN1A,1
WP_CILIARY_LANDSCAPE,WP_CILIARY_LANDSCAPE,1/18,219/21728,0.16674629894893467,0.1924986231109323,0.09939493536209612,VIM,1
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,1/18,223/21728,0.1695322570233887,0.19496209557689698,0.10066692724735632,GADD45B,1
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1/18,223/21728,0.1695322570233887,0.19496209557689698,0.10066692724735632,ITPR2,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1/18,223/21728,0.1695322570233887,0.19496209557689698,0.10066692724735632,CDKN1A,1
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,1/18,224/21728,0.17022737068874938,0.19526080755474193,0.10082116449461533,GADD45B,1
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,1/18,224/21728,0.17022737068874938,0.19526080755474193,0.10082116449461533,KCNJ8,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,1/18,227/21728,0.17230941618497375,0.19739661087857144,0.10192396736087714,VIM,1
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,1/18,229/21728,0.17369470435124468,0.19847662395295093,0.10248162241307096,KLF9,1
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,1/18,229/21728,0.17369470435124468,0.19847662395295093,0.10248162241307096,RHOB,1
KAUFFMANN_DNA_REPAIR_GENES,KAUFFMANN_DNA_REPAIR_GENES,1/18,230/21728,0.17438652700912083,0.19901363196842414,0.10275890167940696,CDKN1A,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/18,236/21728,0.17852598865517788,0.20322057338032307,0.10493111809815425,RHOB,1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,1/18,236/21728,0.17852598865517788,0.20322057338032307,0.10493111809815425,KLF9,1
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,1/18,238/21728,0.17990144779511574,0.20426784642053017,0.10547186812771611,RHOB,1
NABA_ECM_REGULATORS,NABA_ECM_REGULATORS,1/18,238/21728,0.17990144779511574,0.20426784642053017,0.10547186812771611,HTRA1,1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1/18,239/21728,0.18058836142655776,0.20478857168093845,0.10574073993969714,CDKN1A,1
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,1/18,243/21728,0.18333058580682793,0.20763577710697556,0.10721086889288184,CDKN1A,1
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,1/18,246/21728,0.18538156375310932,0.2096938999830253,0.10827356215752056,NAGLU,1
BILD_E2F3_ONCOGENIC_SIGNATURE,BILD_E2F3_ONCOGENIC_SIGNATURE,1/18,248/21728,0.1867461787491813,0.21097143871286603,0.10893320780808669,SREBF1,1
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,1/18,250/21728,0.18810863459490645,0.2119766899894863,0.10945226027738542,MXRA7,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,1/18,250/21728,0.18810863459490645,0.2119766899894863,0.10945226027738542,THBS4,1
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,1/18,251/21728,0.18878905384145162,0.21247651354552333,0.10971033968201639,CDKN1A,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,1/18,256/21728,0.19218307936393508,0.21602534108953603,0.11154274491509227,VIM,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,1/18,258/21728,0.19353693071977862,0.2172748771660093,0.11218793164706226,RHOB,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1/18,262/21728,0.19623820727370822,0.2194833814520153,0.11332827300227276,KCNJ8,1
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,1/18,262/21728,0.19623820727370822,0.2194833814520153,0.11332827300227276,CDKN1A,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,1/18,262/21728,0.19623820727370822,0.2194833814520153,0.11332827300227276,ITPR2,1
AFFAR_YY1_TARGETS_DN,AFFAR_YY1_TARGETS_DN,1/18,263/21728,0.19691218995651205,0.21996293199376254,0.11357588461803149,THBS4,1
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,1/18,265/21728,0.1982585543635429,0.22009643968328957,0.11364482011458947,CDKN1A,1
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,1/18,265/21728,0.1982585543635429,0.22009643968328957,0.11364482011458947,THBS4,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,1/18,265/21728,0.1982585543635429,0.22009643968328957,0.11364482011458947,KCNE4,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,1/18,265/21728,0.1982585543635429,0.22009643968328957,0.11364482011458947,HTRA1,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1/18,265/21728,0.1982585543635429,0.22009643968328957,0.11364482011458947,THBS4,1
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,1/18,266/21728,0.1989309368832961,0.22056990158753598,0.11388928791705197,ITPR2,1
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,1/18,267/21728,0.19960278681042776,0.22104160465302924,0.11413284755891907,GADD45B,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/18,268/21728,0.20027410454200634,0.22151155582512908,0.11437550262636484,VIM,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,1/18,269/21728,0.2009448904748231,0.22197976201467529,0.11461725668773941,HTRA1,1
MEISSNER_BRAIN_HCP_WITH_H3K27ME3,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,1/18,271/21728,0.2022848685299462,0.22318515014927642,0.11523964802638227,THBS4,1
NABA_CORE_MATRISOME,NABA_CORE_MATRISOME,1/18,275/21728,0.20495846048307198,0.22585717328417143,0.11661932317671238,THBS4,1
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,1/18,278/21728,0.2069580982591922,0.22778087624355267,0.11761260992450058,KLF9,1
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,1/18,280/21728,0.20828855022237136,0.22896425189885677,0.11822363531713545,RHOB,1
BHAT_ESR1_TARGETS_VIA_AKT1_UP,BHAT_ESR1_TARGETS_VIA_AKT1_UP,1/18,281/21728,0.2089529854189397,0.22913304146795713,0.11831078829537187,GADD45B,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,1/18,281/21728,0.2089529854189397,0.22913304146795713,0.11831078829537187,MXRA7,1
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,1/18,283/21728,0.21028027620803003,0.2303069691802234,0.11891693532746381,CDKN1A,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,1/18,285/21728,0.21160546347651155,0.23147573260784252,0.11952041582755467,RHOB,1
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,1/18,289/21728,0.21424953999885943,0.23379785569218603,0.12071942322896421,RHOB,1
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,1/18,289/21728,0.21424953999885943,0.23379785569218603,0.12071942322896421,RHOB,1
REACTOME_CELL_CYCLE_CHECKPOINTS,REACTOME_CELL_CYCLE_CHECKPOINTS,1/18,292/21728,0.21622709895524428,0.2356691467349382,0.12168564755427191,CDKN1A,1
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,1/18,293/21728,0.21688524003654708,0.2358134064397366,0.12176013475735979,EMP3,1
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,1/18,293/21728,0.21688524003654708,0.2358134064397366,0.12176013475735979,NAGLU,1
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,1/18,295/21728,0.21819995668278858,0.2369556430320355,0.12234991836425001,SREBF1,1
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,1/18,296/21728,0.2188565330267308,0.2373812698004565,0.1225696869238994,KCNE4,1
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,1/18,299/21728,0.22082313881013738,0.23922506704431548,0.12352171507304915,SCG2,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,1/18,300/21728,0.22147763428362754,0.2393559493402577,0.12358929497120624,KLF9,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,1/18,300/21728,0.22147763428362754,0.2393559493402577,0.12358929497120624,SREBF1,1
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,1/18,301/21728,0.22213161051019492,0.2397738322835678,0.12380506507630093,HTRA1,1
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,1/18,303/21728,0.22343800677322379,0.2408941010523819,0.12438350579481083,MXRA7,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,1/18,307/21728,0.2260445853782811,0.24341175640374327,0.125683474526371,CDKN1A,1
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,1/18,308/21728,0.22669493771772353,0.2438193754589904,0.12589394496503642,ITPR2,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,1/18,309/21728,0.22734477390451502,0.24422546370341314,0.1261036249832797,EMP3,1
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,1/18,311/21728,0.22864289936214244,0.24532617311942798,0.12667196640561906,CDKN1A,1
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,1/18,314/21728,0.2305862260340884,0.24711570460284027,0.127595974916681,ITPR2,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,1/18,317/21728,0.23252492811471925,0.24889601493902525,0.12851522217118008,RHOB,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,1/18,321/21728,0.23510268831543923,0.25135531754344337,0.129785060985877,KLF9,1
REACTOME_RHO_GTPASE_EFFECTORS,REACTOME_RHO_GTPASE_EFFECTORS,1/18,322/21728,0.23574584950618627,0.25144355173251975,0.12983061991704356,RHOB,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1/18,322/21728,0.23574584950618627,0.25144355173251975,0.12983061991704356,VIM,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,1/18,324/21728,0.23703063993178564,0.2525136389772111,0.13038314985621413,FNDC4,1
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,1/18,325/21728,0.2376722699299747,0.2528968281461297,0.13058100614245974,CDKN1A,1
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,1/18,329/21728,0.24023369738509792,0.25531946274221895,0.1318319117603431,ITPR2,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,MULLIGHAN_NPM1_SIGNATURE_3_UP,1/18,335/21728,0.2440606027841482,0.2590797168016343,0.13377348517598908,HTRA1,1
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,1/18,336/21728,0.2446966477123904,0.25944786406384657,0.1339635747087866,ITPR2,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,1/18,339/21728,0.24660175125938766,0.26085114490527206,0.1346881461694769,KLF9,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,1/18,339/21728,0.24660175125938766,0.26085114490527206,0.1346881461694769,MXRA7,1
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,1/18,345/21728,0.25039835175641145,0.26455514902885874,0.1366006754358949,ITPR2,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,1/18,357/21728,0.2579374106356901,0.2718799733727544,0.14038278270728385,ITPR2,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,1/18,357/21728,0.2579374106356901,0.2718799733727544,0.14038278270728385,SCG2,1
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,1/18,359/21728,0.25918693698072615,0.272556485898841,0.14073209387489297,EMP3,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,1/18,359/21728,0.25918693698072615,0.272556485898841,0.14073209387489297,RHOB,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1/18,366/21728,0.2635446485735884,0.27681446108958874,0.142930661127054,CDKN1A,1
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,1/18,369/21728,0.2654048183765425,0.2784422480511797,0.1437711543067759,RHOB,1
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,1/18,378/21728,0.2709587390914019,0.2839369029964807,0.14660827004453622,KLF9,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,1/18,383/21728,0.27402709022275984,0.28681715277691433,0.14809546115336775,KCNE4,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,1/18,385/21728,0.2752510123020313,0.2874274249533435,0.14841056971128458,RHOB,1
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,1/18,385/21728,0.2752510123020313,0.2874274249533435,0.14841056971128458,SCG2,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,1/18,390/21728,0.2783022971638145,0.29027576808830413,0.14988128611025506,SREBF1,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,1/18,392/21728,0.2795194106341302,0.29120663337841446,0.15036193004342235,NAGLU,1
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,1/18,395/21728,0.28134144657419746,0.29242558236043464,0.15099132340385057,HTRA1,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,1/18,395/21728,0.28134144657419746,0.29242558236043464,0.15099132340385057,GADD45B,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,1/18,399/21728,0.28376405911597413,0.29460226970720926,0.15211523636821228,CDKN1A,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,1/18,409/21728,0.28978689046388717,0.30050733034231997,0.15516426139836978,SREBF1,1
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,1/18,410/21728,0.2903865356616757,0.30070757522826047,0.15526765604698073,RHOB,1
REACTOME_NEURONAL_SYSTEM,REACTOME_NEURONAL_SYSTEM,1/18,411/21728,0.29098570267350066,0.30070757522826047,0.15526765604698073,KCNJ8,1
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,1/18,411/21728,0.29098570267350066,0.30070757522826047,0.15526765604698073,VIM,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,1/18,412/21728,0.2915843918582772,0.30097951610687534,0.15540807027756282,KLF9,1
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,1/18,414/21728,0.2927803381810776,0.3018666245384214,0.155866120749757,CDKN1A,1
MOOTHA_PGC,MOOTHA_PGC,1/18,421/21728,0.29695115140002915,0.3058153648746569,0.15790501736178963,ITPR2,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,1/18,422/21728,0.29754508199911844,0.30607561760689134,0.15803939652295043,KLF9,1
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,1/18,423/21728,0.29813853870258333,0.3063347871892523,0.15817321640940094,THBS4,1
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,1/18,425/21728,0.29932403184596457,0.30720098005243734,0.15862046731569845,RHOB,1
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,1/18,428/21728,0.3010987262330689,0.3086692084926432,0.1593785738857748,NAGLU,1
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,1/18,432/21728,0.3034583823706011,0.3107330696192114,0.16044423004453795,CDKN1A,1
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,1/18,433/21728,0.3040471196507162,0.3109809194147006,0.1605722050606915,FNDC4,1
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,1/18,434/21728,0.30463538693628955,0.3112277244668015,0.16069964063297856,KCNE4,1
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,1/18,438/21728,0.3069837631923782,0.3132701201178194,0.16175421328620612,HTRA1,1
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,1/18,446/21728,0.3116580630857487,0.3176787302135416,0.16403055951881515,CDKN1A,1
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,1/18,453/21728,0.3157236345992257,0.32095408429296085,0.16572175918430182,GADD45B,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,1/18,453/21728,0.3157236345992257,0.32095408429296085,0.16572175918430182,KLF9,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,1/18,454/21728,0.3163025758249469,0.32095408429296085,0.16572175918430182,RHOB,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,1/18,454/21728,0.3163025758249469,0.32095408429296085,0.16572175918430182,KCNE4,1
MCCABE_BOUND_BY_HOXC6,MCCABE_BOUND_BY_HOXC6,1/18,458/21728,0.3186137179013707,0.32293390390681304,0.16674402126268584,THBS4,1
MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,1/18,459/21728,0.3191903494518069,0.3231532093208474,0.1668572576438102,ITPR2,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1/18,463/21728,0.32149227018816917,0.32511676026920827,0.1678711195428641,RHOB,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,1/18,467/21728,0.32378683879665104,0.3270684621628333,0.16887886328891236,RHOB,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,1/18,472/21728,0.3266447442969095,0.329584179566173,0.17017783137841477,GADD45B,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,1/18,476/21728,0.328922851343754,0.33150988500600825,0.17117215208900266,CDKN1A,1
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,1/18,481/21728,0.33176024949679506,0.3339943252509822,0.1724549704986589,KLF9,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,1/18,483/21728,0.3328920331158489,0.3343947985972379,0.1726617513146567,SCG2,1
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,1/18,484/21728,0.33345724579666414,0.3343947985972379,0.1726617513146567,FNDC4,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,1/18,484/21728,0.33345724579666414,0.3343947985972379,0.1726617513146567,NAGLU,1
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,1/18,485/21728,0.33402200617962674,0.3343947985972379,0.1726617513146567,EMP3,1
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,1/18,485/21728,0.33402200617962674,0.3343947985972379,0.1726617513146567,KCNJ8,1
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,1/18,496/21728,0.34020461599261553,0.34020461599261553,0.17566159835328388,ITPR2,1
